The	O
role	O
of	O
cellular	B-protein
transcription	I-protein
factor	I-protein
E2F	I-protein
in	O
the	O
regulation	O
of	O
cdc2	B-RNA
mRNA	I-RNA
expression	O
and	O
cell	O
cycle	O
control	O
of	O
human	O
hematopoietic	B-cell_type
cells	I-cell_type
.	O

cdc2	B-RNA
mRNA	I-RNA
transcripts	I-RNA
were	O
detected	O
in	O
immature	B-cell_type
bone	I-cell_type
marrow	I-cell_type
cells	I-cell_type
and	O
became	O
undetectable	O
along	O
with	O
differentiation	O
.	O

Peripheral	B-cell_type
blood	I-cell_type
resting	I-cell_type
cells	I-cell_type
did	O
not	O
express	O
cdc2	B-RNA
mRNA	I-RNA
,	O
but	O
it	O
was	O
induced	O
in	O
T-lymphocytes	B-cell_type
when	O
the	O
cells	O
reentered	O
the	O
cell	O
cycle	O
in	O
response	O
to	O
specific	O
mitogens	O
.	O

In	O
contrast	O
,	O
cdc2	B-RNA
mRNA	I-RNA
could	O
not	O
be	O
induced	O
in	O
granulocytes	B-cell_type
and	O
monocytes	B-cell_type
even	O
after	O
the	O
culture	O
with	O
the	O
appropriate	O
stimulants	O
.	O

In	O
order	O
to	O
investigate	O
the	O
mechanism	O
of	O
the	O
regulation	O
of	O
cdc2	B-RNA
mRNA	I-RNA
expression	O
in	O
hematopoietic	B-cell_type
cells	I-cell_type
,	O
we	O
isolated	O
the	O
5'-flanking	B-DNA
sequence	I-DNA
of	O
the	O
cdc2	B-DNA
gene	I-DNA
and	O
found	O
the	O
putative	O
E2F	O
binding	B-DNA
site	I-DNA
at	O
the	O
position	O
of	O
nucleotides	B-DNA
-124	I-DNA
to	I-DNA
-117	I-DNA
.	O

The	O
binding	O
of	O
E2F	B-protein
at	O
this	O
region	O
was	O
detected	O
by	O
a	O
gel-retardation	O
assay	O
and	O
DNaseI	B-protein
footprinting	O
in	O
phytohemagglutinin-stimulated	B-cell_line
T-lymphocytes	I-cell_line
,	O
which	O
was	O
coincident	O
with	O
the	O
expression	O
of	O
cdc2	B-RNA
mRNA	I-RNA
.	O

E2F	B-protein
binding	O
was	O
not	O
observed	O
in	O
both	O
granulocytes	B-cell_type
and	O
monocytes	B-cell_type
.	O

Transient	O
chloramphenicol	B-protein
acetyltransferase	I-protein
assay	O
revealed	O
that	O
the	O
region	O
containing	O
E2F	B-DNA
binding	I-DNA
site	I-DNA
had	O
a	O
strong	O
promoter	O
activity	O
,	O
and	O
introduction	O
of	O
the	O
mutation	O
at	O
the	O
E2F	B-DNA
binding	I-DNA
site	I-DNA
resulted	O
in	O
a	O
significant	O
loss	O
of	O
the	O
activity	O
.	O

E2F-1	B-RNA
and	I-RNA
DP-1	I-RNA
mRNAs	I-RNA
were	O
not	O
detectable	O
in	O
granulocytes	B-cell_type
,	O
monocytes	B-cell_type
and	O
resting	B-cell_type
T-lymphocytes	I-cell_type
but	O
were	O
induced	O
after	O
the	O
mitogenic	O
stimulation	O
of	O
T-lymphocytes	B-cell_type
.	O

The	O
induction	O
of	O
E2F	B-protein
activity	O
preceded	O
the	O
appearance	O
of	O
cdc2	B-RNA
mRNA	I-RNA
,	O
which	O
is	O
consistent	O
with	O
the	O
role	O
of	O
E2F	B-protein
in	O
the	O
regulation	O
of	O
cdc2	B-cell_type
mRNA	I-cell_type
expression	I-cell_type
.	O

These	O
results	O
suggest	O
that	O
cdc2	B-RNA
mRNA	I-RNA
expression	O
is	O
related	O
to	O
the	O
cell	O
cycling	O
of	O
normal	B-cell_type
human	I-cell_type
hematopoietic	I-cell_type
cells	I-cell_type
and	O
that	O
E2F	B-protein
plays	O
some	O
roles	O
in	O
the	O
regulation	O
of	O
its	O
expression	O
.	O

Tis	NULL
Journar	NULL
or	NULL
Brovocicat	NULL
.	NULL

.	NULL

Â©	NULL
1994	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

269	NULL
,	NULL
No	NULL
.	NULL

42	NULL
,	NULL
Issue	NULL
of	NULL
October	NULL
21	NULL
,	NULL
pp	NULL
.	NULL

26249-26258	NULL
,	NULL
1994	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

The	NULL
Role	NULL
of	NULL
Cellular	NULL
Transcription	NULL
Factor	NULL
E2F	NULL
in	NULL
the	NULL
Regulation	NULL
of	NULL
edc2	NULL
mRNA	NULL
Expression	NULL
and	NULL
Cell	NULL
Cycle	NULL
Control	NULL
of	NULL
Human	NULL
Hematopoietic	NULL
Cells*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
May	NULL
31	NULL
,	NULL
1994	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
July	NULL
28	NULL
,	NULL
1994	NULL
)	NULL
Yusuke	NULL
Furukawa	NULL
,	NULL
Yasuhito	NULL
Terui	NULL
,	NULL
Kumi	NULL
Sakoe	NULL
,	NULL
Masatsugu	NULL
Ohta	NULL
,	NULL
and	NULL
Masaki	NULL
Saito	NULL
?	NULL

From	NULL
the	NULL
Division	NULL
of	NULL
Hemopotesis	NULL
,	NULL
Institute	NULL
of	NULL
Hematology	NULL
,	NULL
Jichi	NULL
Medical	NULL
School	NULL
,	NULL
Tochigi	NULL
329-04	NULL
,	NULL
Japan	NULL
cde2	NULL
mRNA	NULL
transcripts	NULL
were	NULL
detected	NULL
in	NULL
immature	NULL
bone	NULL
marrow	NULL
cells	NULL
and	NULL
became	NULL
undetectable	NULL
along	NULL
with	NULL
differentiation	NULL
.	NULL

Peripheral	NULL
blood	NULL
resting	NULL
cells	NULL
did	NULL
not	NULL
express	NULL
cdc2	NULL
mRNA	NULL
,	NULL
but	NULL
it	NULL
was	NULL
induced	NULL
in	NULL
lymphocytes	NULL
when	NULL
the	NULL
cells	NULL
reentered	NULL
the	NULL
cell	NULL
cycle	NULL
in	NULL
response	NULL
to	NULL
specific	NULL
mitogens	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
ede2	NULL
mRNA	NULL
could	NULL
not	NULL
be	NULL
induced	NULL
in	NULL
granulocytes	NULL
and	NULL
monocytes	NULL
even	NULL
after	NULL
the	NULL
culture	NULL
with	NULL
the	NULL
appropriate	NULL
stimulants	NULL
.	NULL

In	NULL
order	NULL
to	NULL
investigate	NULL
the	NULL
mechanism	NULL
of	NULL
the	NULL
regulation	NULL
of	NULL
edc2	NULL
mRNA	NULL
expression	NULL
in	NULL
hematopoietic	NULL
cells	NULL
,	NULL
we	NULL
isolated	NULL
the	NULL
-flanking	NULL
sequence	NULL
of	NULL
the	NULL
ede2	NULL
gene	NULL
and	NULL
found	NULL
the	NULL
putative	NULL
E2F	NULL
binding	NULL
site	NULL
at	NULL
the	NULL
position	NULL
of	NULL
nucleotides	NULL
-124	NULL
to	NULL
-117	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
E2F	NULL
at	NULL
this	NULL
region	NULL
was	NULL
detected	NULL
by	NULL
a	NULL
gel-retardation	NULL
assay	NULL
and	NULL
DNasel	NULL
footprinting	NULL
in	NULL
phytohemagglutinin-stimulated	NULL
T-lymphocytes	NULL
,	NULL
which	NULL
was	NULL
coincident	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
cedc2	NULL
mRNA	NULL
.	NULL

E2F	NULL
binding	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
both	NULL
granulocytes	NULL
and	NULL
monocytes	NULL
.	NULL

Transient	NULL
chloramphenicol	NULL
acetyltransferase	NULL
assay	NULL
revealed	NULL
that	NULL
the	NULL
region	NULL
containing	NULL
E2F	NULL
binding	NULL
site	NULL
had	NULL
a	NULL
strong	NULL
promoter	NULL
activity	NULL
,	NULL
and	NULL
introduction	NULL
of	NULL
the	NULL
mutation	NULL
at	NULL
the	NULL
E2F	NULL
binding	NULL
site	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
loss	NULL
of	NULL
the	NULL
activity	NULL
.	NULL

EZ2F-1	NULL
and	NULL
DP-1	NULL
mRNAs	NULL
were	NULL
not	NULL
detectable	NULL
in	NULL
granulocytes	NULL
,	NULL
monocytes	NULL
and	NULL
resting	NULL
T-lymphocytes	NULL
but	NULL
were	NULL
induced	NULL
after	NULL
the	NULL
mitogenic	NULL
stimulation	NULL
of	NULL
T-lymphocytes	NULL
.	NULL

The	NULL
indue-tion	NULL
of	NULL
E2F	NULL
activity	NULL
preceded	NULL
the	NULL
appearance	NULL
of	NULL
ecdc2	NULL
mRNA	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
role	NULL
of	NULL
E2F	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
edc2	NULL
mRNA	NULL
expression	NULL
,	NULL
These	NULL
results	NULL
suggest	NULL
that	NULL
ede2	NULL
mRNA	NULL
expression	NULL
is	NULL
related	NULL
to	NULL
the	NULL
cell	NULL
cycling	NULL
of	NULL
normal	NULL
human	NULL
hematopoietic	NULL
cells	NULL
and	NULL
that	NULL
EZF	NULL
plays	NULL
some	NULL
roles	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
its	NULL
expression	NULL
.	NULL

The	NULL
division	NULL
cycle	NULL
of	NULL
eukaryotic	NULL
cells	NULL
is	NULL
regulated	NULL
by	NULL
a	NULL
family	NULL
of	NULL
protein	NULL
kinases	NULL
known	NULL
as	NULL
the	NULL
cyclin-dependent	NULL
kinases	NULL
.	NULL

At	NULL
least	NULL
five	NULL
cyclin-dependent	NULL
kinases	NULL
were	NULL
now	NULL
well	NULL
character-ized	NULL
,	NULL
and	NULL
the	NULL
sequential	NULL
activation	NULL
of	NULL
individual	NULL
members	NULL
of	NULL
this	NULL
family	NULL
and	NULL
their	NULL
consequent	NULL
phosphorylation	NULL
of	NULL
critical	NULL
substrates	NULL
such	NULL
as	NULL
the	NULL
retinoblastoma	NULL
susceptibility	NULL
gene	NULL
product	NULL
(	NULL
Rb	NULL
)	NULL
promotes	NULL
orderly	NULL
progression	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
a	NULL
grant-in-aid	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
Science	NULL
and	NULL
Culture	NULL
of	NULL
Japan	NULL
and	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Yamanouchi	NULL
Foundation	NULL
for	NULL
Research	NULL
on	NULL
Metabolic	NULL
Disorders	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertise-ment	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
(	NULL
s	NULL
)	NULL
reported	NULL
in	NULL
this	NULL
paper	NULL
has	NULL
been	NULL
submitted	NULL
to	NULL
the	NULL
GenBank	NULL
``	NULL
/	NULL
EMBL	NULL
Data	NULL
Bank	NULL
with	NULL
accession	NULL
number	NULL
(	NULL
s	NULL
)	NULL
D32223	NULL
.	NULL

{	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Div	NULL
.	NULL

of	NULL
Hemopoiesis	NULL
,	NULL
Inst	NULL
.	NULL

of	NULL
Hematology	NULL
,	NULL
Jichi	NULL
Medical	NULL
School	NULL
,	NULL
Minamikawachi-machi	NULL
,	NULL
Kawachi-gun	NULL
,	NULL
Tochigi	NULL
329-04	NULL
,	NULL
Japan	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
81-285-44-2111	NULL
;	NULL
Fax	NULL
:	NULL
81-285-44-1317	NULL
.	NULL

'The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
Rb	NULL
,	NULL
retinoblastoma	NULL
susceptibility	NULL
gene	NULL
product	NULL
;	NULL
PHA	NULL
,	NULL
phytohemagglutinin	NULL
;	NULL
CSF	NULL
,	NULL
colony-stimulating	NULL
factor	NULL
;	NULL
RB	NULL
,	NULL
check	NULL
points	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Among	NULL
them	NULL
,	NULL
the	NULL
role	NULL
of	NULL
CDC2	NULL
in	NULL
cell	NULL
cycle	NULL
control	NULL
has	NULL
been	NULL
most	NULL
extensively	NULL
investigated	NULL
.	NULL

The	NULL
cdc2	NULL
gene	NULL
was	NULL
originally	NULL
identified	NULL
in	NULL
fission	NULL
yeast	NULL
as	NULL
an	NULL
essential	NULL
cell	NULL
cycle	NULL
control	NULL
element	NULL
for	NULL
both	NULL
(	NULL
G	NULL
,	NULL
/S	NULL
and	NULL
G	NULL
,	NULL
/M	NULL
transition	NULL
(	NULL
3	NULL
)	NULL
.	NULL

It	NULL
encodes	NULL
a	NULL
serine/threonine	NULL
kinase	NULL
designated	NULL
as	NULL
p34	NULL
``	NULL
,	NULL
which	NULL
is	NULL
now	NULL
known	NULL
to	NULL
be	NULL
a	NULL
catalytic	NULL
subunit	NULL
of	NULL
the	NULL
mitosis-regulating	NULL
protein	NULL
kinase	NULL
complex	NULL
known	NULL
as	NULL
maturation	NULL
promoting	NULL
factor	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

Both	NULL
biochemical	NULL
and	NULL
genetic	NULL
experiments	NULL
implicate	NULL
an	NULL
involvement	NULL
of	NULL
CDCZ	NULL
homologue	NULL
in	NULL
regulation	NULL
of	NULL
mitotic	NULL
initiation	NULL
in	NULL
mammalian	NULL
cells	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
,	NULL
whereas	NULL
other	NULL
members	NULL
of	NULL
cyclin-dependent	NULL
kinases	NULL
especially	NULL
cyclin-dependent	NULL
kinases	NULL
2	NULL
and	NULL
4	NULL
were	NULL
reported	NULL
to	NULL
mediate	NULL
G	NULL
,	NULL
to	NULL
S	NULL
transition	NULL
instead	NULL
of	NULL
CDC2	NULL
(	NULL
8-10	NULL
)	NULL
.	NULL

Posttranslational	NULL
regulation	NULL
is	NULL
believed	NULL
to	NULL
be	NULL
fundamentally	NULL
important	NULL
in	NULL
the	NULL
control	NULL
of	NULL
CDC2	NULL
kinase	NULL
func-tion	NULL
,	NULL
ie	NULL
.	NULL

the	NULL
activity	NULL
of	NULL
p34	NULL
``	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
complex	NULL
formation	NULL
with	NULL
cyclins	NULL
(	NULL
11	NULL
)	NULL
and	NULL
phosphorylation	NULL
of	NULL
tyrosine	NULL
15	NULL
(	NULL
12	NULL
)	NULL
and	NULL
threonine	NULL
161	NULL
(	NULL
13	NULL
)	NULL
.	NULL

However	NULL
,	NULL
recent	NULL
evidence	NULL
suggests	NULL
that	NULL
only	NULL
a	NULL
newly	NULL
synthesized	NULL
CDCZ	NULL
protein	NULL
can	NULL
be	NULL
modified	NULL
and	NULL
activated	NULL
for	NULL
exhibiting	NULL
its	NULL
kinase	NULL
activity	NULL
.	NULL

Thus	NULL
,	NULL
regulation	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
might	NULL
also	NULL
be	NULL
important	NULL
for	NULL
a	NULL
control	NULL
of	NULL
CDC2	NULL
kinase	NULL
activity	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
,	NULL
There	NULL
is	NULL
an	NULL
increasing	NULL
evidence	NULL
that	NULL
p34	NULL
``	NULL
levels	NULL
in	NULL
mammalian	NULL
cells	NULL
are	NULL
modulated	NULL
in	NULL
response	NULL
to	NULL
cellular	NULL
growth	NULL
states	NULL
by	NULL
regulating	NULL
levels	NULL
of	NULL
ecde2	NULL
mRNA	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
earlier	NULL
observations	NULL
in	NULL
the	NULL
yeast	NULL
(	NULL
16	NULL
)	NULL
.	NULL

ede2	NULL
mRNA	NULL
is	NULL
almost	NULL
undetectable	NULL
in	NULL
resting	NULL
cells	NULL
such	NULL
as	NULL
peripheral	NULL
blood	NULL
T-lymphocytes	NULL
or	NULL
serum-starved	NULL
fibroblasts	NULL
and	NULL
it	NULL
increased	NULL
in	NULL
a	NULL
regulatory	NULL
manner	NULL
as	NULL
cells	NULL
enter	NULL
the	NULL
cell	NULL
cycle	NULL
by	NULL
mitogenic	NULL
stimuli	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
cdce2	NULL
mRNA	NULL
transcript	NULL
is	NULL
constitutively	NULL
expressed	NULL
in	NULL
the	NULL
certain	NULL
subsets	NULL
of	NULL
cancer	NULL
cells	NULL
or	NULL
cell	NULL
lines	NULL
of	NULL
which	NULL
substantial	NULL
numbers	NULL
are	NULL
in	NULL
a	NULL
cycling	NULL
state	NULL
(	NULL
19	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
edc2	NULL
expression	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
is	NULL
as	NULL
important	NULL
as	NULL
the	NULL
posttranslational	NULL
modifications	NULL
in	NULL
cell	NULL
cycle	NULL
control	NULL
of	NULL
higher	NULL
eukaryotic	NULL
cells	NULL
.	NULL

Recently	NULL
,	NULL
there	NULL
have	NULL
been	NULL
three	NULL
reports	NULL
dealing	NULL
with	NULL
analysis	NULL
of	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
cde2	NULL
gene	NULL
(	NULL
20-22	NULL
)	NULL
.	NULL

However	NULL
,	NULL
these	NULL
papers	NULL
contain	NULL
some	NULL
conflicting	NULL
results	NULL
,	NULL
and	NULL
a	NULL
precise	NULL
analysis	NULL
of	NULL
transcriptional	NULL
regulation	NULL
of	NULL
edc2	NULL
gene	NULL
in	NULL
a	NULL
particular	NULL
cell	NULL
system	NULL
such	NULL
as	NULL
hematopoietic	NULL
cells	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
reported	NULL
.	NULL

Hematopoietic	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
are	NULL
known	NULL
to	NULL
be	NULL
tightly	NULL
regulated	NULL
in	NULL
a	NULL
cell	NULL
cycle-dependent	NULL
manner	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Primary	NULL
hematopoietic	NULL
cells	NULL
are	NULL
gradually	NULL
losing	NULL
their	NULL
cell	NULL
cycling	NULL
capacity	NULL
along	NULL
with	NULL
differentiation	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
hemopoiesis	NULL
is	NULL
closely	NULL
related	NULL
to	NULL
the	NULL
function	NULL
of	NULL
cell	NULL
cycle	NULL
control	NULL
genes	NULL
.	NULL

Therefore	NULL
,	NULL
analysis	NULL
of	NULL
cell	NULL
cycle	NULL
control	NULL
elements	NULL
is	NULL
important	NULL
for	NULL
a	NULL
better	NULL
understanding	NULL
of	NULL
the	NULL
regulatory	NULL
mechanisms	NULL
of	NULL
hematopoietic	NULL
cell	NULL
growth	NULL
and	NULL
differen-	NULL
retinoblastoma	NULL
susceptibility	NULL
gene	NULL
;	NULL
GM-CSF	NULL
,	NULL
granulocyte-macrophage	NULL
CSF	NULL
;	NULL
G-CSF	NULL
,	NULL
granulocyte	NULL
CSF	NULL
;	NULL
M-CSF	NULL
,	NULL
macrophage	NULL
CSF	NULL
;	NULL
PCR	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
;	NULL
RCE	NULL
,	NULL
retinoblastoma	NULL
control	NULL
element	NULL
;	NULL
nt	NULL
,	NULL
nucleo-tide	NULL
(	NULL
s	NULL
)	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
kb	NULL
,	NULL
kilobase	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
.	NULL

26249	NULL
26250	NULL
tiation	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
and	NULL
others	NULL
have	NULL
shown	NULL
that	NULL
expression	NULL
of	NULL
CDC2	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
proliferation	NULL
of	NULL
normal	NULL
hematopoietic	NULL
cells	NULL
,	NULL
i.e	NULL
.	NULL

proliferation	NULL
of	NULL
immature	NULL
bone	NULL
marrow	NULL
cells	NULL
or	NULL
mitogen-stimulated	NULL
T-lymphocytes	NULL
was	NULL
inhibited	NULL
by	NULL
blocking	NULL
the	NULL
expression	NULL
of	NULL
cdc2	NULL
mRNA	NULL
with	NULL
antisense	NULL
oligonucleotides	NULL
(	NULL
18	NULL
,	NULL
24	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
expression	NULL
of	NULL
cde2	NULL
mRNA	NULL
in	NULL
various	NULL
types	NULL
of	NULL
human	NULL
hematopoietic	NULL
cells	NULL
and	NULL
investigated	NULL
the	NULL
mechanisms	NULL
of	NULL
its	NULL
regulation	NULL
.	NULL

We	NULL
have	NULL
found	NULL
that	NULL
1	NULL
)	NULL
cde2	NULL
mRNA	NULL
expression	NULL
is	NULL
correlated	NULL
with	NULL
cell	NULL
cycle	NULL
status	NULL
of	NULL
hematopoietic	NULL
cells	NULL
,	NULL
2	NULL
)	NULL
the	NULL
changes	NULL
in	NULL
chromatin	NULL
structure	NULL
and	NULL
DNA	NULL
methylation	NULL
status	NULL
are	NULL
not	NULL
likely	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cde2	NULL
mRNA	NULL
expression	NULL
in	NULL
normal	NULL
hematopoietic	NULL
cells	NULL
and	NULL
,	NULL
instead	NULL
,	NULL
3	NULL
)	NULL
a	NULL
cellular	NULL
transcription	NULL
factor	NULL
E2F	NULL
plays	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cdc2	NULL
mRNA	NULL
expression	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Preparation	NULL
and	NULL
Culture	NULL
--	NULL
T-lymphocytes	NULL
were	NULL
prepared	NULL
by	NULL
erythrocyte	NULL
rosetting	NULL
from	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
isolated	NULL
by	NULL
sedimentation	NULL
on	NULL
Ficoll-Hypaque	NULL
density	NULL
gradients	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Monocytes	NULL
were	NULL
purified	NULL
from	NULL
the	NULL
mononuclear	NULL
cell	NULL
fraction	NULL
by	NULL
the	NULL
centrifugal	NULL
elutriation	NULL
in	NULL
a	NULL
Hitachi	NULL
SRR6Y	NULL
rotor	NULL
(	NULL
Hitachi	NULL
Ltd.	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Granulocytes	NULL
were	NULL
prepared	NULL
by	NULL
dextran	NULL
sedimentation	NULL
as	NULL
described	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Myeloid	NULL
cells	NULL
at	NULL
various	NULL
stages	NULL
of	NULL
differentiation	NULL
were	NULL
prepared	NULL
from	NULL
bone	NULL
marrow	NULL
mononuclear	NULL
cells	NULL
using	NULL
dextran	NULL
sedimentation	NULL
and	NULL
Ficoll-Conray	NULL
(	NULL
Mallinckrodt	NULL
Inc.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Immature	NULL
and	NULL
mature	NULL
myeloid	NULL
cells	NULL
were	NULL
separated	NULL
into	NULL
three	NULL
fractions	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Fraction	NULL
I	NULL
was	NULL
obtained	NULL
from	NULL
the	NULL
interface	NULL
layer	NULL
and	NULL
mainly	NULL
contained	NULL
myeloblasts	NULL
and	NULL
promyelocytes	NULL
.	NULL

Fraction	NULL
II	NULL
was	NULL
from	NULL
the	NULL
Ficoll-Conray	NULL
layer	NULL
and	NULL
mainly	NULL
contained	NULL
myelocytes	NULL
and	NULL
metamy-elocytes	NULL
.	NULL

Fraction	NULL
III	NULL
was	NULL
from	NULL
the	NULL
bottom	NULL
and	NULL
contained	NULL
segmented	NULL
neutrophils	NULL
.	NULL

All	NULL
samples	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
healthy	NULL
volunteers	NULL
after	NULL
informed	NULL
consent	NULL
and	NULL
under	NULL
institutional	NULL
review	NULL
board-approved	NULL
protocols	NULL
.	NULL

Human	NULL
leukemic	NULL
cell	NULL
lines	NULL
HL-60	NULL
and	NULL
JOSK-I	NULL
were	NULL
maintained	NULL
as	NULL
described	NULL
previously	NULL
and	NULL
used	NULL
as	NULL
controls	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Human	NULL
small	NULL
cell	NULL
lung	NULL
cancer	NULL
cell	NULL
line	NULL
LU65	NULL
,	NULL
which	NULL
is	NULL
defective	NULL
for	NULL
the	NULL
retinoblastoma	NULL
susceptibility	NULL
gene	NULL
(	NULL
RB	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
the	NULL
Japanese	NULL
Cancer	NULL
Research	NULL
Resources	NULL
Bank	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Primary	NULL
cells	NULL
were	NULL
cultured	NULL
at	NULL
2-5	NULL
x	NULL
10Â°	NULL
cells/ml	NULL
for	NULL
a	NULL
given	NULL
culture	NULL
period	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
Flow	NULL
Laboratories	NULL
,	NULL
McLean	NULL
,	NULL
VA	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
Commonwealth	NULL
Serum	NULL
Laboratories	NULL
,	NULL
Melbourne	NULL
,	NULL
Australia	NULL
)	NULL
with	NULL
appropriate	NULL
stimulants	NULL
.	NULL

DNA	NULL
synthesis	NULL
was	NULL
monitored	NULL
by	NULL
[	NULL
*H	NULL
)	NULL
thymidine	NULL
uptake	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
30	NULL
)	NULL
,	NULL
and	NULL
the	NULL
results	NULL
were	NULL
shown	NULL
as	NULL
a	NULL
stimulation	NULL
index	NULL
(	NULL
cpm	NULL
of	NULL
the	NULL
sample/cpm	NULL
of	NULL
the	NULL
unstimulated	NULL
control	NULL
)	NULL
.	NULL

Recombinant	NULL
human	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
and	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
G-CSF	NULL
)	NULL
were	NULL
provided	NULL
by	NULL
Dr.	NULL
Steven	NULL
Clark	NULL
,	NULL
Genetics	NULL
Institute	NULL
(	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
and	NULL
Kirin	NULL
Brewery	NULL
Co.	NULL
Ltd.	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Recombinant	NULL
human	NULL
macrophage-colony-stimulating	NULL
factor	NULL
(	NULL
M-CSF	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Cellular	NULL
Products	NULL
Inc.	NULL
(	NULL
Buffalo	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Phytohemagglutinin	NULL
(	NULL
PHA	NULL
)	NULL
-P	NULL
was	NULL
purchased	NULL
from	NULL
Seikagaku	NULL
Kogyo	NULL
Co.	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

DNA	NULL
Clones-The	NULL
following	NULL
cDNA	NULL
clones	NULL
were	NULL
used	NULL
in	NULL
this	NULL
study	NULL
:	NULL
a	NULL
0.9-kb	NULL
KpnI-Pvull	NULL
fragment	NULL
of	NULL
human	NULL
ede	NULL
?	NULL

cDNA	NULL
(	NULL
provided	NULL
by	NULL
Dr.	NULL
Paul	NULL
Nurse	NULL
(	NULL
Oxford	NULL
University	NULL
,	NULL
Oxford	NULL
,	NULL
United	NULL
Kingdom	NULL
)	NULL
(	NULL
81	NULL
)	NULL
,	NULL
a	NULL
1.8-kb	NULL
Hin-dIlI	NULL
fragment	NULL
of	NULL
human	NULL
B-actin	NULL
cDNA	NULL
(	NULL
provided	NULL
by	NULL
Dr.	NULL
Kiyoshi	NULL
Nose	NULL
,	NULL
Institute	NULL
of	NULL
Medical	NULL
Science	NULL
,	NULL
University	NULL
of	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
a	NULL
840-bp	NULL
Smal	NULL
fragment	NULL
of	NULL
human	NULL
myeloperoxidase	NULL
cDNA	NULL
(	NULL
provided	NULL
by	NULL
Dr.	NULL
Michiyuki	NULL
Yamada	NULL
,	NULL
Institute	NULL
for	NULL
Protein	NULL
Research	NULL
,	NULL
Osaka	NULL
University	NULL
)	NULL
(	NULL
32	NULL
)	NULL
,	NULL
and	NULL
a	NULL
1.4-kb	NULL
EcoRI-BamHI	NULL
fragment	NULL
of	NULL
human	NULL
E2F-U/RBAP-1	NULL
cDNA	NULL
(	NULL
provided	NULL
by	NULL
Drs	NULL
.	NULL

William	NULL
G.	NULL
Kaelin	NULL
Jr.	NULL
,	NULL
James	NULL
A.	NULL
DeCaprio	NULL
,	NULL
and	NULL
David	NULL
M.	NULL
Livingston	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
(	NULL
83	NULL
)	NULL
.	NULL

A	NULL
1.3-kb	NULL
full-length	NULL
fragment	NULL
of	NULL
murine	NULL
DP-1	NULL
cDNA	NULL
was	NULL
generated	NULL
by	NULL
reverse-transcription	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
based	NULL
on	NULL
the	NULL
published	NULL
sequence	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Oligonucleotides-All	NULL
oligodeoxynucleotides	NULL
used	NULL
in	NULL
this	NULL
study	NULL
were	NULL
synthesized	NULL
with	NULL
a	NULL
Cyclon	NULL
Plus	NULL
DNA	NULL
synthesizer	NULL
(	NULL
Milligen	NULL
Biosearch	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
and	NULL
purified	NULL
by	NULL
chromatography	NULL
on	NULL
Sep-Pak	NULL
C	NULL
,	NULL
,	NULL
columns	NULL
and	NULL
ethanol	NULL
precipitation	NULL
.	NULL

Northern	NULL
Blotting-Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
cesium	NULL
chloride	NULL
centrifugation	NULL
after	NULL
lysing	NULL
the	NULL
cells	NULL
in	NULL
4	NULL
m	NULL
guanidium	NULL
isothiocya-nate	NULL
solution	NULL
.	NULL

Ten-microgram	NULL
samples	NULL
were	NULL
electrophoresed	NULL
in	NULL
a	NULL
1	NULL
%	NULL
formaldehyde-containing	NULL
agarose	NULL
gel	NULL
and	NULL
blotted	NULL
onto	NULL
a	NULL
synthetic	NULL
nylon	NULL
cde2	NULL
Expression	NULL
in	NULL
Hematopoietic	NULL
Cells	NULL
membrane	NULL
as	NULL
described	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
hybridized	NULL
with	NULL
each	NULL
cDNA	NULL
probe	NULL
,	NULL
which	NULL
was	NULL
labeled	NULL
with	NULL
[	NULL
*Â°P	NULL
]	NULL
dCTP	NULL
(	NULL
DuPont	NULL
NEN	NULL
)	NULL
by	NULL
the	NULL
oligonucleotide	NULL
random	NULL
priming	NULL
method	NULL
.	NULL

To	NULL
monitor	NULL
the	NULL
equal	NULL
loading	NULL
of	NULL
RNA	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
rehybridized	NULL
with	NULL
B-actin	NULL
probe	NULL
or	NULL
the	NULL
ethidium	NULL
bromide	NULL
staining	NULL
of	NULL
the	NULL
gel	NULL
was	NULL
shown	NULL
.	NULL

Western	NULL
Bloiting-Immunoblot	NULL
analysis	NULL
of	NULL
Rb	NULL
and	NULL
CDC2	NULL
proteins	NULL
was	NULL
performed	NULL
with	NULL
anti-Rb	NULL
monoclonal	NULL
antibody	NULL
PMG3-245	NULL
(	NULL
Pharm-ingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
anti-p34	NULL
``	NULL
``	NULL
(	NULL
MBL	NULL
,	NULL
Nagoya	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
respectively	NULL
(	NULL
30	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
Sensitivity	NULL
Assay	NULL
and	NULL
Southern	NULL
Blotting-DNase	NULL
I	NULL
sensitivity	NULL
assay	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
by	NULL
Lubbert	NULL
et	NULL
al	NULL
.	NULL

(	NULL
35	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
nuclei	NULL
were	NULL
isolated	NULL
by	NULL
suspension	NULL
of	NULL
the	NULL
cells	NULL
in	NULL
ice-cold	NULL
RSB	NULL
buffer	NULL
(	NULL
10	NULL
mix	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
3	NULL
mu	NULL
MgC1	NULL
,	NULL
,	NULL
10	NULL
mm	NULL
KCH	NULL
and	NULL
0.3	NULL
%	NULL
Nonidet	NULL
P-40	NULL
.	NULL

Pellets	NULL
were	NULL
rinsed	NULL
twice	NULL
and	NULL
resuspended	NULL
at	NULL
1	NULL
x	NULL
in	NULL
RSB	NULL
.	NULL

A	NULL
series	NULL
of	NULL
nuclei	NULL
(	NULL
2	NULL
x	NULL
10	NULL
``	NULL
/point	NULL
)	NULL
were	NULL
digested	NULL
for	NULL
5	NULL
min	NULL
at	NULL
37	NULL
Â°C	NULL
with	NULL
increasing	NULL
concentrations	NULL
(	NULL
ranging	NULL
from	NULL
0	NULL
to	NULL
1.4	NULL
ug/ml	NULL
!	NULL
)	NULL

of	NULL
pancreatic	NULL
DNase	NULL
I	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
terminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
400	NULL
ul	NULL
of	NULL
proteinase	NULL
K	NULL
digestion	NULL
buffer	NULL
(	NULL
150	NULL
ug/ml	NULL
of	NULL
proteinase	NULL
K	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
0.5	NULL
%	NULL
SDS	NULL
,	NULL
10	NULL
mm	NULL
EDTA	NULL
,	NULL
10	NULL
my	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.4	NULL
)	NULL
.	NULL

DNA	NULL
was	NULL
isolated	NULL
by	NULL
isopropyl	NULL
alcobol	NULL
precipitation	NULL
after	NULL
deproteinization	NULL
for	NULL
16	NULL
h	NULL
at	NULL
50	NULL
Â°C	NULL
.	NULL

Ten-microgram	NULL
samples	NULL
were	NULL
digested	NULL
with	NULL
restriction	NULL
endonucleases	NULL
,	NULL
separated	NULL
on	NULL
0.8	NULL
%	NULL
agarose	NULL
gels	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
nylon	NULL
membrane	NULL
.	NULL

Hybridization	NULL
was	NULL
performed	NULL
with	NULL
a	NULL
219-bp	NULL
fragment	NULL
of	NULL
cdc2	NULL
cDNA	NULL
corresponding	NULL
to	NULL
nucleotides	NULL
14-232	NULL
(	NULL
5'-cde	NULL
probe	NULL
)	NULL
,	NULL
which	NULL
was	NULL
prepared	NULL
by	NULL
PCR	NULL
,	NULL
purified	NULL
by	NULL
gel	NULL
electrophoresis	NULL
,	NULL
and	NULL
labeled	NULL
with	NULL
[	NULL
P	NULL
]	NULL
dCTP	NULL
.	NULL

Methylation	NULL
analysis	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
digesting	NULL
genomic	NULL
DNA	NULL
with	NULL
either	NULL
Hapli-Mspl	NULL
(	NULL
Takara	NULL
Biomedicals	NULL
,	NULL
Kyoto	NULL
,	NULL
Japan	NULL
)	NULL
or	NULL
Smal-Xmal	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
,	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
as	NULL
described	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Digested	NULL
DNA	NULL
samples	NULL
were	NULL
analyzed	NULL
on	NULL
Southern	NULL
blotting	NULL
as	NULL
above	NULL
.	NULL

Isolation	NULL
of	NULL
5'-regulatory	NULL
Sequence	NULL
by	NULL
a	NULL
Ligation-mediated	NULL
PCR-5'-Regulatory	NULL
sequence	NULL
of	NULL
the	NULL
ecdc2	NULL
gene	NULL
was	NULL
isolated	NULL
by	NULL
a	NULL
ligation-mediated	NULL
single-sided	NULL
PCR	NULL
according	NULL
to	NULL
the	NULL
method	NULL
described	NULL
by	NULL
Fors	NULL
et	NULL
al	NULL
.	NULL

(	NULL
36	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
15	NULL
ug	NULL
of	NULL
genomic	NULL
DNA	NULL
from	NULL
HL-60	NULL
were	NULL
digested	NULL
with	NULL
Hindlll	NULL
,	NULL
EcoR1	NULL
,	NULL
Poull	NULL
,	NULL
and	NULL
Pstl	NULL
and	NULL
extracted	NULL
with	NULL
phenoV/chloroform/	NULL
isoamyl	NULL
alcohol	NULL
followed	NULL
by	NULL
ethanol	NULL
precipitation	NULL
.	NULL

The	NULL
resulting	NULL
pellet	NULL
was	NULL
used	NULL
in	NULL
the	NULL
primer	NULL
extension	NULL
for	NULL
30	NULL
min	NULL
at	NULL
50	NULL
Â°C	NULL
with	NULL
Sequenase	NULL
version	NULL
2.0	NULL
(	NULL
U.	NULL
S.	NULL
Biochemical	NULL
Corp.	NULL
)	NULL
and	NULL
0.3	NULL
pm	NULL
specific	NULL
primer	NULL
cde2	NULL
5'-1	NULL
(	NULL
antisense	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
nucleotide	NULL
80-103	NULL
of	NULL
ede2	NULL
eDNA	NULL
;	NULL
5'-CAGCCACTGTACCCGGCTTATTAT-3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
blunt	NULL
end	NULL
of	NULL
the	NULL
linker	NULL
LMPCR-1/2	NULL
(	NULL
LMPCR-1	NULL
;	NULL
5'-GCGGTGACcCCcGaGagaTCT-GAATTC-3	NULL
'	NULL
,	NULL
LMPCR-2	NULL
;	NULL
5'-GAATTCAGATC-3	NULL
'	NULL
)	NULL
was	NULL
ligated	NULL
to	NULL
the	NULL
blunt	NULL
end	NULL
of	NULL
the	NULL
extended	NULL
DNA	NULL
and	NULL
subsequently	NULL
used	NULL
for	NULL
a	NULL
PCR	NULL
amplification	NULL
(	NULL
37	NULL
)	NULL
.	NULL

The	NULL
PCR	NULL
reaction	NULL
was	NULL
performed	NULL
in	NULL
a	NULL
100	NULL
pl	NULL
of	NULL
solution	NULL
containing	NULL
200	NULL
um	NULL
of	NULL
all	NULL
four	NULL
dNTPs	NULL
,	NULL
1	NULL
um	NULL
of	NULL
each	NULL
primer	NULL
(	NULL
LMPCR-1	NULL
and	NULL
edc2	NULL
5-1	NULL
for	NULL
the	NULL
first	NULL
amplification	NULL
,	NULL
LMPCR-1	NULL
and	NULL
antisense	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
nucleotide	NULL
66-90	NULL
of	NULL
ede2	NULL
cDNA	NULL
;	NULL
TATTATTCCGCGGCGGCGC-3	NULL
'	NULL
[	NULL
AS-1	NULL
]	NULL
for	NULL
the	NULL
second	NULL
amplification	NULL
)	NULL
,	NULL
10	NULL
mx	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.3	NULL
,	NULL
50	NULL
mw	NULL
KCl	NULL
,	NULL
2.5	NULL
my	NULL
MgCl	NULL
,	NULL
,	NULL
2.5	NULL
units	NULL
of	NULL
Taq	NULL
polymerase	NULL
(	NULL
Perkin-Elmer	NULL
Corp.	NULL
)	NULL
and	NULL
template	NULL
DNA	NULL
(	NULL
70	NULL
ul	NULL
of	NULL
ligated	NULL
DNA	NULL
solution	NULL
for	NULL
the	NULL
first	NULL
amplification	NULL
,	NULL
10	NULL
pl	NULL
of	NULL
the	NULL
PCR	NULL
product	NULL
for	NULL
the	NULL
second	NULL
amplification	NULL
)	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
denatured	NULL
for	NULL
7	NULL
min	NULL
at	NULL
94	NULL
Â°C	NULL
,	NULL
followed	NULL
by	NULL
30	NULL
cycles	NULL
of	NULL
amplification	NULL
(	NULL
94	NULL
Â°C	NULL
,	NULL
1	NULL
min	NULL
for	NULL
denaturation	NULL
;	NULL
63	NULL
Â°C	NULL
,	NULL
2	NULL
min	NULL
for	NULL
annealing	NULL
;	NULL
and	NULL
76	NULL
Â°C	NULL
,	NULL
3	NULL
min	NULL
for	NULL
extension	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
PCR	NULL
products	NULL
were	NULL
subcloned	NULL
into	NULL
pCR	NULL
II	NULL
vectors	NULL
by	NULL
a	NULL
TA	NULL
cloning	NULL
system	NULL
(	NULL
Invitrogen	NULL
Co.	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
transformed	NULL
into	NULL
competent	NULL
INV	NULL
F	NULL
``	NULL
cells	NULL
.	NULL

DNA	NULL
sequencing	NULL
was	NULL
performed	NULL
by	NULL
the	NULL
dideoxy	NULL
chain	NULL
termination	NULL
method	NULL
using	NULL
Bst	NULL
DNA	NULL
polymerase	NULL
(	NULL
Bio-Rad	NULL
)	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Gel	NULL
Retardation	NULL
Assay-Protein-DNA	NULL
interaction	NULL
was	NULL
analyzed	NULL
by	NULL
a	NULL
mobility	NULL
shift	NULL
DNA	NULL
binding	NULL
assay	NULL
using	NULL
high	NULL
ionic	NULL
strength	NULL
polyaeryl-amide	NULL
gel	NULL
electrophoresis	NULL
as	NULL
described	NULL
by	NULL
Chodosh	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
a	NULL
miniextract	NULL
method	NULL
according	NULL
to	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

(	NULL
40	NULL
)	NULL
since	NULL
only	NULL
relatively	NULL
small	NULL
numbers	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
primary	NULL
cultures	NULL
of	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Protein	NULL
sample	NULL
(	NULL
2-4	NULL
ug	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
approximately	NULL
10,000	NULL
cpm	NULL
(	NULL
0.2	NULL
ng	NULL
)	NULL
of	NULL
an	NULL
end-labeled	NULL
DNA	NULL
fragment	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
-	NULL
poly	NULL
(	NULL
d1-dC	NULL
)	NULL
and	NULL
300	NULL
ug/ml	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
23-25	NULL
ul	NULL
.	NULL

Incubations	NULL
were	NULL
carried	NULL
out	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
in	NULL
12	NULL
mm	NULL
Hepes	NULL
pH	NULL
7.9	NULL
,	NULL
4	NULL
mm	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8	NULL
,	NULL
60	NULL
mm	NULL
KCI	NULL
,	NULL
5	NULL
mu	NULL
MgC	NULL
)	NULL
,	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
1	NULL
mm	NULL
dithiothreitol	NULL
,	NULL
and	NULL
12	NULL
%	NULL
glycerol	NULL
.	NULL

The	NULL
protein-DNA	NULL
complexes	NULL
were	NULL
resolved	NULL
on	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
(	NULL
0.15	NULL
x	NULL
16	NULL
x	NULL
20	NULL
cm	NULL
;	NULL
acrylamide/bisacrylamide	NULL
weight	NULL
ratio	NULL
of	NULL
86:1	NULL
)	NULL
in	NULL
a	NULL
buffer	NULL
consisting	NULL
of	NULL
50	NULL
mm	NULL
Tris-HCl	NULL
,	NULL
0.4	NULL
m	NULL
glycine	NULL
,	NULL
and	NULL
2	NULL
mm	NULL
EDTA	NULL
at	NULL
4	NULL
Â°C	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
each	NULL
oligonucleotide	NULL
for	NULL
a	NULL
competition	NULL
assay	NULL
was	NULL
as	NULL
follows	NULL
(	NULL
only	NULL
sense	NULL
strands	NULL
were	NULL
shown	NULL
)	NULL
:	NULL
E2F	NULL
,	NULL
5'-CTAGATTTCGCGCG-3	NULL
'	NULL
;	NULL
AP-1	NULL
,	NULL
SP-1	NULL
,	NULL
5-GATC-GATCGGGGCGGGGCGATC-3	NULL
'	NULL
.	NULL

For	NULL
antibody	NULL
perturbation	NULL
experi-ments	NULL
,	NULL
0.5	NULL
ug	NULL
of	NULL
each	NULL
antibody	NULL
was	NULL
added	NULL
to	NULL
the	NULL
above-noted	NULL
reaction	NULL
mixture	NULL
.	NULL

The	NULL
monoclonal	NULL
antibodies	NULL
used	NULL
in	NULL
this	NULL
study	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
ede2	NULL
Expression	NULL
in	NULL
Hematopoietic	NULL
Cells	NULL
BM	NULL
cell	NULL
fraction	NULL
cdc2	NULL
mRNA	NULL
__	NULL
<	NULL
(	NULL
1.8kb	NULL
)	NULL
___	NULL
|	NULL
a	NULL
-	NULL
(	NULL
1.6kb	NULL
)	NULL
B-actin	NULL
mRNA	NULL
(	NULL
tu	NULL
tat	NULL
>	NULL
u	NULL
-	NULL
Â»	NULL
(	NULL
1.8kb	NULL
)	NULL
oig/s9g	NULL
eien/o94n	NULL
bas/qes	NULL
I-	NULL
MSOF	NULL
Fic	NULL
.	NULL

1.	NULL
ede2	NULL
mRNA	NULL
expression	NULL
during	NULL
granulocytic	NULL
differentiation	NULL
.	NULL

Myeloid	NULL
cells	NULL
at	NULL
various	NULL
stages	NULL
of	NULL
differentiation	NULL
were	NULL
prepared	NULL
from	NULL
normal	NULL
bone	NULL
marrow	NULL
mononuclear	NULL
cells	NULL
by	NULL
the	NULL
dextran	NULL
sedimentation	NULL
and	NULL
Ficoll-Conray	NULL
separation	NULL
.	NULL

RNA	NULL
was	NULL
isolated	NULL
from	NULL
each	NULL
frac-tion	NULL
,	NULL
and	NULL
ede2	NULL
mRNA	NULL
expression	NULL
was	NULL
examined	NULL
by	NULL
Northern	NULL
blotting	NULL
.	NULL

Leukemia	NULL
cell	NULL
line	NULL
JOSK-I	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
rehybridized	NULL
with	NULL
-actin	NULL
probe	NULL
to	NULL
show	NULL
the	NULL
amounts	NULL
of	NULL
RNA	NULL
loaded	NULL
.	NULL

anti-Rb	NULL
antibody	NULL
PMG3-245	NULL
,	NULL
anti-cyclin	NULL
A	NULL
antibody	NULL
CHLA-3.13	NULL
(	NULL
UBI	NULL
,	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
and	NULL
anti-p107	NULL
S.D.9	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Deoxycholate	NULL
treatment	NULL
of	NULL
E2F-containing	NULL
complexes	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
by	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
(	NULL
41	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
Footprinting-In	NULL
vitro	NULL
DNase	NULL
I	NULL
footprinting	NULL
was	NULL
performed	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Carthew	NULL
et	NULL
al	NULL
.	NULL

(	NULL
42	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
protein-DNA	NULL
samples	NULL
were	NULL
treated	NULL
with	NULL
5	NULL
ug/ml	NULL
of	NULL
DNase	NULL
I	NULL
for	NULL
60	NULL
s	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
resolved	NULL
as	NULL
above	NULL
.	NULL

Radioactive	NULL
complexes	NULL
were	NULL
excised	NULL
from	NULL
the	NULL
gel	NULL
and	NULL
treated	NULL
overnight	NULL
in	NULL
0.5	NULL
m	NULL
NH	NULL
,	NULL
OAc	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
0.1	NULL
mm	NULL
EDTA	NULL
,	NULL
10	NULL
ug/ml	NULL
proteinase	NULL
K	NULL
,	NULL
and	NULL
10	NULL
ug/ml	NULL
tRNA	NULL
.	NULL

The	NULL
eluted	NULL
DNA	NULL
was	NULL
precipitated	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
15	NULL
%	NULL
polyacrylamide	NULL
,	NULL
7	NULL
m	NULL
urea	NULL
sequencing	NULL
gel	NULL
.	NULL

Transient	NULL
Transfection	NULL
and	NULL
Chloramphenicol	NULL
Acetyltransferase	NULL
Assays-Plasmids	NULL
were	NULL
introduced	NULL
into	NULL
NIH	NULL
3T3	NULL
cells	NULL
by	NULL
the	NULL
calcium-phosphate	NULL
precipitation	NULL
method	NULL
as	NULL
described	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Mutation	NULL
was	NULL
introduced	NULL
into	NULL
the	NULL
putative	NULL
E2F	NULL
binding	NULL
site	NULL
by	NULL
PCR	NULL
using	NULL
mutated	NULL
primers	NULL
that	NULL
corresponds	NULL
to	NULL
nucleotides	NULL
-132	NULL
to	NULL
-108	NULL
and	NULL
changes	NULL
CG	NULL
to	NULL
AT	NULL
at	NULL
the	NULL
core	NULL
sequence	NULL
(	NULL
S-2	NULL
;	NULL
AS-2	NULL
;	NULL
5-GTGGCTAGAGATCGAAAGAAAGAGG-3	NULL
'	NULL
)	NULL
.	NULL

A	NULL
270-bp	NULL
fragment	NULL
corresponding	NULL
to	NULL
nucleotides	NULL
-377	NULL
to	NULL
-108	NULL
was	NULL
amplified	NULL
with	NULL
primers	NULL
S-1	NULL
(	NULL
nucleotides	NULL
-377	NULL
to	NULL
-354	NULL
;	NULL
5'-TTAGAAGTGAAAGTAATGGAATCT-3	NULL
'	NULL
)	NULL
and	NULL
AS-2	NULL
.	NULL

A	NULL
222-bp	NULL
fragment	NULL
corresponding	NULL
to	NULL
nucleotides	NULL
-132	NULL
to	NULL
+90	NULL
was	NULL
also	NULL
amplified	NULL
with	NULL
primers	NULL
S-2	NULL
and	NULL
AS-1	NULL
.	NULL

A	NULL
467-bp	NULL
fragment	NULL
containing	NULL
mutant	NULL
E2F	NULL
binding	NULL
site	NULL
was	NULL
prepared	NULL
by	NULL
PCR	NULL
using	NULL
above	NULL
two	NULL
fragments	NULL
as	NULL
templates	NULL
and	NULL
primers	NULL
S-1/AS-1	NULL
.	NULL

Wild-type	NULL
fragment	NULL
was	NULL
prepared	NULL
in	NULL
a	NULL
same	NULL
manner	NULL
using	NULL
genomic	NULL
DNA	NULL
as	NULL
a	NULL
template	NULL
and	NULL
primers	NULL
S-1/AS-1	NULL
.	NULL

These	NULL
fragments	NULL
were	NULL
subcloned	NULL
into	NULL
pCRII	NULL
vectors	NULL
,	NULL
and	NULL
the	NULL
recombinant	NULL
clones	NULL
were	NULL
subjected	NULL
to	NULL
a	NULL
sequencing	NULL
analysis	NULL
to	NULL
confirm	NULL
the	NULL
introduction	NULL
of	NULL
the	NULL
expected	NULL
mutation	NULL
.	NULL

A	NULL
HindIII/Xbal	NULL
fragment	NULL
from	NULL
these	NULL
clones	NULL
was	NULL
subcloned	NULL
into	NULL
pCAT-basic	NULL
and	NULL
pCAT-enhancer	NULL
vectors	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
for	NULL
analysis	NULL
of	NULL
the	NULL
promoter	NULL
activity	NULL
.	NULL

pCAT-control	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
SV40	NULL
promoter	NULL
and	NULL
enhancer	NULL
sequences	NULL
,	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
for	NULL
chloramphenicol	NULL
acetyltransferase	NULL
assay	NULL
.	NULL

pSV-B-gal	NULL
(	NULL
Promega	NULL
)	NULL
was	NULL
co-trans-fected	NULL
with	NULL
test	NULL
plasmids	NULL
to	NULL
monitor	NULL
the	NULL
transfection	NULL
efficiencies	NULL
of	NULL
each	NULL
plate	NULL
.	NULL

NIH	NULL
3T3	NULL
cells	NULL
were	NULL
left	NULL
with	NULL
the	NULL
precipitates	NULL
for	NULL
16	NULL
h	NULL
and	NULL
harvested	NULL
after	NULL
48	NULL
h	NULL
to	NULL
prepare	NULL
the	NULL
cell	NULL
extracts	NULL
.	NULL

Chloramphenicol	NULL
acetyltransferase	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
duplicate	NULL
,	NULL
and	NULL
the	NULL
activities	NULL
were	NULL
measured	NULL
simultaneously	NULL
by	NULL
a	NULL
thin-layer	NULL
chromatography	NULL
and	NULL
by	NULL
a	NULL
liquid-scintillation	NULL
counting	NULL
according	NULL
to	NULL
the	NULL
standard	NULL
procedures	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

RESULTS	NULL
Expression	NULL
of	NULL
edc2	NULL
mRNA	NULL
in	NULL
Human	NULL
Primary	NULL
Hematopoietic	NULL
Cells-Expression	NULL
of	NULL
ecde2	NULL
mRNA	NULL
was	NULL
examined	NULL
by	NULL
Northern	NULL
blotting	NULL
in	NULL
hematopoietic	NULL
cells	NULL
from	NULL
the	NULL
healthy	NULL
volunteers	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
ede2	NULL
mRNA	NULL
transcripts	NULL
(	NULL
1.8	NULL
and	NULL
1.6	NULL
kb	NULL
)	NULL
were	NULL
readily	NULL
detected	NULL
in	NULL
immature	NULL
blasts/promyelocytes	NULL
fraction	NULL
of	NULL
bone	NULL
marrow	NULL
cells	NULL
and	NULL
became	NULL
undetectable	NULL
after	NULL
the	NULL
myelocytes/metamyelocytes	NULL
stage	NULL
in	NULL
granulocytic	NULL
differentiation	NULL
.	NULL

The	NULL
significant	NULL
proportion	NULL
(	NULL
20-40	NULL
%	NULL
)	NULL
of	NULL
leukemic	NULL
cells	NULL
such	NULL
26251	NULL
as	NULL
HL-60	NULL
or	NULL
JOSK-I	NULL
are	NULL
in	NULL
S	NULL
and	NULL
G	NULL
,	NULL
/M	NULL
phases	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

cde2	NULL
mRNA	NULL
expression	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
peripheral	NULL
blood	NULL
resting	NULL
cells	NULL
(	NULL
more	NULL
than	NULL
95	NULL
%	NULL
are	NULL
in	NULL
G/G	NULL
,	NULL
phase	NULL
)	NULL
including	NULL
mature	NULL
granulocytes	NULL
,	NULL
monocytes	NULL
,	NULL
and	NULL
T-lymphocytes	NULL
did	NULL
not	NULL
express	NULL
cde2	NULL
mRNA	NULL
transcripts	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
ecde2	NULL
mRNA	NULL
transcripts	NULL
could	NULL
be	NULL
induced	NULL
in	NULL
T-lymphocytes	NULL
after	NULL
48	NULL
h	NULL
of	NULL
the	NULL
stimulation	NULL
with	NULL
2	NULL
ug/ml	NULL
of	NULL
PHA-P	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
reentry	NULL
into	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

This	NULL
is	NULL
fully	NULL
consistent	NULL
with	NULL
previous	NULL
reports	NULL
,	NULL
including	NULL
ours	NULL
(	NULL
18	NULL
,	NULL
45	NULL
,	NULL
46	NULL
)	NULL
.	NULL

ecde2	NULL
mRNA	NULL
expression	NULL
could	NULL
not	NULL
be	NULL
induced	NULL
in	NULL
mature	NULL
granulocytes	NULL
even	NULL
after	NULL
the	NULL
culture	NULL
with	NULL
20	NULL
ng/ml	NULL
GM-CSF	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
or	NULL
5	NULL
ng/ml	NULL
G-CSF	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
for	NULL
24	NULL
h.	NULL
ecde2	NULL
mRNA	NULL
transcripts	NULL
were	NULL
also	NULL
absent	NULL
in	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
even	NULL
after	NULL
the	NULL
culture	NULL
with	NULL
10	NULL
ng/ml	NULL
of	NULL
GM-CSF	NULL
or	NULL
3000	NULL
units/ml	NULL
of	NULL
M-CSF	NULL
up	NULL
to	NULL
72	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
cell	NULL
activation-related	NULL
genes	NULL
such	NULL
as	NULL
interleu-kin-1	NULL
receptor	NULL
antagonist	NULL
was	NULL
strongly	NULL
positive	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
induction	NULL
of	NULL
CDC2	NULL
expression	NULL
in	NULL
monocytes	NULL
and	NULL
granulocytes	NULL
was	NULL
also	NULL
confirmed	NULL
at	NULL
the	NULL
level	NULL
of	NULL
protein	NULL
products	NULL
by	NULL
Western	NULL
blotting	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
cde2	NULL
mRNA	NULL
expression	NULL
is	NULL
important	NULL
for	NULL
the	NULL
proliferation	NULL
and	NULL
cell	NULL
cycling	NULL
of	NULL
normal	NULL
hematopoietic	NULL
cells	NULL
and	NULL
that	NULL
the	NULL
failure	NULL
to	NULL
induce	NULL
CDC2	NULL
expression	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
terminal	NULL
differentiation	NULL
of	NULL
hematopoietic	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
also	NULL
suggested	NULL
that	NULL
deregulation	NULL
of	NULL
ecde2	NULL
mRNA	NULL
expression	NULL
might	NULL
be	NULL
implicated	NULL
in	NULL
the	NULL
altered	NULL
growth	NULL
of	NULL
leukemic	NULL
cells	NULL
.	NULL

The	NULL
Changes	NULL
in	NULL
Chromatin	NULL
Structure	NULL
and	NULL
DNA	NULL
Methylation	NULL
Status	NULL
of	NULL
the	NULL
edc2	NULL
Gene	NULL
in	NULL
Hematopoietic	NULL
Cells-Recent	NULL
observations	NULL
suggest	NULL
that	NULL
the	NULL
changes	NULL
in	NULL
chromatin	NULL
structure	NULL
as	NULL
characterized	NULL
by	NULL
the	NULL
appearance	NULL
of	NULL
DNase	NULL
I	NULL
hypersensitivity	NULL
sites	NULL
or	NULL
the	NULL
alteration	NULL
of	NULL
DNA	NULL
methylation	NULL
status	NULL
were	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
tissue-specific	NULL
or	NULL
differentiation-specific	NULL
expression	NULL
of	NULL
genes	NULL
such	NULL
as	NULL
myeloperoxidase	NULL
(	NULL
35	NULL
)	NULL
and	NULL
B-globin	NULL
(	NULL
47	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
examined	NULL
whether	NULL
these	NULL
changes	NULL
were	NULL
observed	NULL
in	NULL
hematopoietic	NULL
cells	NULL
in	NULL
accordance	NULL
with	NULL
ede2	NULL
mRNA	NULL
expression	NULL
.	NULL

First	NULL
,	NULL
chromatin	NULL
structure	NULL
of	NULL
the	NULL
cdc2	NULL
gene	NULL
was	NULL
evaluated	NULL
by	NULL
DNase	NULL
I	NULL
treatment	NULL
of	NULL
isolated	NULL
nuclei	NULL
from	NULL
HL-60	NULL
cells	NULL
and	NULL
by	NULL
Southern	NULL
blotting	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
the	NULL
structure	NULL
of	NULL
myeloperoxidase	NULL
gene	NULL
was	NULL
examined	NULL
in	NULL
the	NULL
same	NULL
manner	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
an	NULL
18-kb	NULL
germline	NULL
band	NULL
,	NULL
four	NULL
subbands	NULL
,	NULL
designated	NULL
HS-1	NULL
through	NULL
HS-4	NULL
,	NULL
became	NULL
detectable	NULL
on	NULL
myeloperoxidase	NULL
Southern	NULL
blotting	NULL
in	NULL
the	NULL
cells	NULL
treated	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
DNase	NULL
I	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
size	NULL
of	NULL
each	NULL
subband	NULL
was	NULL
consistent	NULL
with	NULL
previous	NULL
reports	NULL
:	NULL
HS-1	NULL
,	NULL
7.0	NULL
kb	NULL
;	NULL
HS-2	NULL
,	NULL
3.5	NULL
kb	NULL
;	NULL
HS-3	NULL
,	NULL
2.7	NULL
kb	NULL
;	NULL
and	NULL
HS-4	NULL
,	NULL
1.7	NULL
kb	NULL
(	NULL
35	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
hypersensitivity	NULL
analysis	NULL
was	NULL
performed	NULL
on	NULL
the	NULL
cdc2	NULL
gene	NULL
using	NULL
the	NULL
same	NULL
samples	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
a	NULL
15-kb	NULL
germline	NULL
band	NULL
,	NULL
two	NULL
weak	NULL
subbands	NULL
(	NULL
2.5	NULL
and	NULL
2.1	NULL
kb	NULL
)	NULL
representing	NULL
DNase	NULL
I	NULL
hypersensitivity	NULL
sites	NULL
in	NULL
the	NULL
cdc2	NULL
gene	NULL
were	NULL
observed	NULL
in	NULL
HL-60	NULL
cells	NULL
,	NULL
which	NULL
constitutively	NULL
expressed	NULL
cde2	NULL
mRNA	NULL
transcripts	NULL
.	NULL

The	NULL
same	NULL
type	NULL
of	NULL
subbands	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
another	NULL
leukemic	NULL
cell	NULL
line	NULL
,	NULL
JOSK-I	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
no	NULL
detectable	NULL
subbands	NULL
were	NULL
present	NULL
in	NULL
resting	NULL
T-lymphocytes	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
lack	NULL
of	NULL
ede2	NULL
mRNA	NULL
expression	NULL
.	NULL

However	NULL
,	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
sites	NULL
were	NULL
not	NULL
observed	NULL
in	NULL
T-lymphocytes	NULL
after	NULL
the	NULL
culture	NULL
with	NULL
PHA-P	NULL
for	NULL
48	NULL
h	NULL
in	NULL
spite	NULL
of	NULL
the	NULL
induction	NULL
of	NULL
cde2	NULL
mRNA	NULL
transcripts	NULL
and	NULL
the	NULL
cell	NULL
cycle	NULL
entry	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

No	NULL
detectable	NULL
hypersensitivity	NULL
sites	NULL
were	NULL
present	NULL
in	NULL
immature	NULL
bone	NULL
marrow	NULL
cells	NULL
and	NULL
in	NULL
mature	NULL
granulocytes	NULL
both	NULL
before	NULL
and	NULL
after	NULL
culture	NULL
with	NULL
GM-CSF	NULL
or	NULL
G-CSF	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
regulatory	NULL
mechanism	NULL
of	NULL
ede2	NULL
mRNA	NULL
expression	NULL
in	NULL
normal	NULL
cdc2-expressing	NULL
hematopoietic	NULL
cells	NULL
is	NULL
possibly	NULL
different	NULL
from	NULL
that	NULL
of	NULL
leukemia	NULL
cells	NULL
,	NULL
and	NULL
hence	NULL
,	NULL
abnormalities	NULL
in	NULL
this	NULL
mechanism	NULL
might	NULL
contribute	NULL
to	NULL
the	NULL
deregulated	NULL
expression	NULL
of	NULL
edc2	NULL
in	NULL
leukemia	NULL
cells	NULL
.	NULL

26252	NULL
T-cell	NULL
Granulocyte	NULL
b4	NULL
43	NULL
%	NULL
0	NULL
_	NULL
48	NULL
0	NULL
_	NULL
24	NULL
GM-CSF	NULL
09-7H	NULL
I-	NULL
4S0r	NULL
ede2	NULL
Expression	NULL
in	NULL
Hematopoietic	NULL
Cells	NULL
Monocyte	NULL
cdc2	NULL
mRNA	NULL
--	NULL
(	NULL
1.8kb	NULL
)	NULL
--	NULL
(	NULL
1.6kb	NULL
)	NULL
--	NULL
18s	NULL
rRNA	NULL
0	NULL
-	NULL
24	NULL
48	NULL
72	NULL
(	NULL
h	NULL
)	NULL
GM-CSF	NULL
Fic	NULL
.	NULL

2.	NULL
ede2	NULL
mRNA	NULL
expression	NULL
in	NULL
various	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Normal	NULL
peripheral	NULL
blood	NULL
T-lymphocytes	NULL
,	NULL
granulocytes	NULL
,	NULL
and	NULL
monocytes	NULL
were	NULL
cultured	NULL
for	NULL
24-72	NULL
h	NULL
with	NULL
2	NULL
ug/ml	NULL
of	NULL
PHA-P	NULL
or	NULL
20	NULL
ng/ml	NULL
of	NULL
GM-CSF	NULL
as	NULL
indicated	NULL
.	NULL

RNA	NULL
was	NULL
isolated	NULL
at	NULL
given	NULL
time	NULL
points	NULL
and	NULL
subjected	NULL
to	NULL
Northern	NULL
blot	NULL
analysis	NULL
for	NULL
cde2	NULL
mRNA	NULL
expression	NULL
.	NULL

Two	NULL
leukemia	NULL
cell	NULL
lines	NULL
,	NULL
HL-60	NULL
and	NULL
JOSK-I	NULL
,	NULL
were	NULL
used	NULL
as	NULL
positive	NULL
controls	NULL
.	NULL

Ethidium	NULL
bromide	NULL
staining	NULL
of	NULL
the	NULL
gel	NULL
is	NULL
shown	NULL
to	NULL
indicate	NULL
the	NULL
amounts	NULL
of	NULL
RNA	NULL
loaded	NULL
.	NULL

Regulation	NULL
of	NULL
tissue-	NULL
or	NULL
differentiation-specific	NULL
gene	NULL
expression	NULL
is	NULL
often	NULL
associated	NULL
with	NULL
changes	NULL
in	NULL
methylation	NULL
of	NULL
cytidine	NULL
residues	NULL
at	NULL
dinucleotide	NULL
sequence	NULL
CpG	NULL
in	NULL
the	NULL
-flanking	NULL
region	NULL
of	NULL
the	NULL
gene	NULL
(	NULL
48	NULL
)	NULL
.	NULL

The	NULL
methylation	NULL
status	NULL
of	NULL
the	NULL
5'-region	NULL
of	NULL
the	NULL
edc2	NULL
gene	NULL
was	NULL
assessed	NULL
both	NULL
in	NULL
cde2-expressing	NULL
cells	NULL
(	NULL
HL-60	NULL
and	NULL
PHA-stimulated	NULL
T-lymphocytes	NULL
)	NULL
and	NULL
in	NULL
cde2	NULL
nonexpressing	NULL
cells	NULL
(	NULL
resting	NULL
T-lymphocytes	NULL
,	NULL
resting	NULL
and	NULL
stimulated	NULL
monocytes	NULL
,	NULL
and	NULL
granulocytes	NULL
)	NULL
.	NULL

Genomic	NULL
DNA	NULL
from	NULL
these	NULL
cells	NULL
were	NULL
digested	NULL
with	NULL
methylation-sensitive	NULL
restriction	NULL
enzymes	NULL
(	NULL
HapII	NULL
and	NULL
Smal	NULL
)	NULL
and	NULL
methylation-insensitive	NULL
isoschizomers	NULL
(	NULL
MspI	NULL
and	NULL
Xmal	NULL
)	NULL
followed	NULL
by	NULL
Southern	NULL
blotting	NULL
with	NULL
5'-cde2	NULL
cDNA	NULL
probe	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
methylation	NULL
status	NULL
was	NULL
not	NULL
different	NULL
between	NULL
edc2-expressors	NULL
including	NULL
HL-60	NULL
cell	NULL
line	NULL
and	NULL
nonexpressors	NULL
in	NULL
this	NULL
experiment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
above	NULL
findings	NULL
indicate	NULL
that	NULL
the	NULL
changes	NULL
in	NULL
chromatin	NULL
structure	NULL
and	NULL
DNA	NULL
methylation	NULL
are	NULL
not	NULL
implicated	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
ecde2	NULL
mRNA	NULL
expression	NULL
in	NULL
normal	NULL
hematopoietic	NULL
cells	NULL
,	NULL
although	NULL
only	NULL
a	NULL
limited	NULL
part	NULL
of	NULL
the	NULL
methylation	NULL
sites	NULL
could	NULL
be	NULL
analyzed	NULL
in	NULL
the	NULL
method	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
DNase	NULL
I	NULL
hypersensitivity	NULL
site	NULL
is	NULL
responsible	NULL
for	NULL
cde2	NULL
mRNA	NULL
expression	NULL
in	NULL
leukemic	NULL
cells	NULL
as	NULL
shown	NULL
in	NULL
HL-60	NULL
and	NULL
JOSK-I	NULL
cell	NULL
lines	NULL
.	NULL

Detailed	NULL
analysis	NULL
on	NULL
this	NULL
subject	NULL
will	NULL
be	NULL
reported	NULL
elsewhere	NULL
.	NULL
``	NULL

These	NULL
results	NULL
prompted	NULL
us	NULL
to	NULL
isolate	NULL
5'-regulatory	NULL
segment	NULL
of	NULL
the	NULL
cdc2	NULL
gene	NULL
and	NULL
to	NULL
examine	NULL
the	NULL
role	NULL
of	NULL
transacting	NULL
factors	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
ecde2	NULL
mRNA	NULL
expression	NULL
in	NULL
normal	NULL
hematopoietic	NULL
cells	NULL
.	NULL

The	NULL
Structure	NULL
of	NULL
5'-regulatory	NULL
Element	NULL
of	NULL
the	NULL
edc2	NULL
Gene-An	NULL
approximately	NULL
850-bp	NULL
fragment	NULL
has	NULL
been	NULL
isolated	NULL
after	NULL
the	NULL
second	NULL
round	NULL
of	NULL
a	NULL
ligation-mediated	NULL
PCR	NULL
.	NULL

A	NULL
part	NULL
of	NULL
the	NULL
sequence	NULL
was	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

The	NULL
sequence	NULL
analysis	NULL
revealed	NULL
that	NULL
approximately	NULL
50	NULL
bp	NULL
were	NULL
identical	NULL
to	NULL
the	NULL
5'-region	NULL
of	NULL
ecde2	NULL
cDNA	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
CAP	NULL
site	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
primer	NULL
extension	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
shown	NULL
as	NULL
-1	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

These	NULL
results	NULL
were	NULL
consistent	NULL
with	NULL
the	NULL
findings	NULL
reported	NULL
by	NULL
others	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

Although	NULL
a	NULL
TATA-like	NULL
element	NULL
was	NULL
present	NULL
at	NULL
the	NULL
position	NULL
of	NULL
nucleotides	NULL
-311	NULL
to	NULL
-306	NULL
and	NULL
a	NULL
CCAAT	NULL
motif	NULL
was	NULL
noted	NULL
at	NULL
the	NULL
position	NULL
of	NULL
nucleotides	NULL
-291	NULL
to	NULL
-287	NULL
,	NULL
these	NULL
elements	NULL
were	NULL
located	NULL
too	NULL
far	NULL
upstream	NULL
from	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
as	NULL
active	NULL
regulatory	NULL
elements	NULL
.	NULL

The	NULL
sequence	NULL
analysis	NULL
also	NULL
revealed	NULL
a	NULL
putative	NULL
E2F	NULL
binding	NULL
site	NULL
at	NULL
the	NULL
posi-	NULL
2	NULL
Y.	NULL
Furukawa	NULL
,	NULL
Y.	NULL
Terui	NULL
,	NULL
and	NULL
M.	NULL
Saito	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
.	NULL

tion	NULL
of	NULL
nucleotides	NULL
-124	NULL
to	NULL
-117	NULL
(	NULL
5-TTTCGCGC-3	NULL
)	NULL
and	NULL
two	NULL
core	NULL
sequences	NULL
of	NULL
the	NULL
retinoblastoma	NULL
control	NULL
element	NULL
(	NULL
RCE	NULL
)	NULL
at	NULL
the	NULL
positions	NULL
of	NULL
nucleotides	NULL
-112	NULL
to	NULL
-106	NULL
(	NULL
5'-GCCACCC-3	NULL
'	NULL
)	NULL
and	NULL
-165	NULL
to	NULL
-159	NULL
(	NULL
5'-CCCGCCC-3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
whole	NULL
region	NULL
was	NULL
included	NULL
in	NULL
the	NULL
sequence	NULL
active	NULL
enough	NULL
for	NULL
transactivation	NULL
of	NULL
a	NULL
chloramphenicol	NULL
acetyltransferase	NULL
reporter	NULL
construct	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Recent	NULL
evidences	NULL
suggest	NULL
that	NULL
both	NULL
E2F	NULL
and	NULL
Rb	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
cell	NULL
cycle	NULL
control	NULL
of	NULL
eukaryotic	NULL
cells	NULL
(	NULL
49	NULL
,	NULL
50	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
investigated	NULL
the	NULL
actual	NULL
interaction	NULL
of	NULL
these	NULL
molecules	NULL
with	NULL
the	NULL
isolated	NULL
segment	NULL
of	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
edec2	NULL
gene	NULL
in	NULL
order	NULL
to	NULL
clarify	NULL
the	NULL
role	NULL
of	NULL
E2F	NULL
and	NULL
Rb	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
ede2	NULL
mRNA	NULL
expression	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Binding	NULL
of	NULL
E2F	NULL
Protein	NULL
to	NULL
a	NULL
Putative	NULL
E2F	NULL
Binding	NULL
Site	NULL
in	NULL
5'-Regulatory	NULL
Sequence	NULL
of	NULL
the	NULL
edc2	NULL
Gene-To	NULL
investigate	NULL
the	NULL
role	NULL
of	NULL
E2F	NULL
and	NULL
Rb	NULL
proteins	NULL
in	NULL
transactivation	NULL
of	NULL
cdc2	NULL
gene	NULL
expression	NULL
,	NULL
gel-retardation	NULL
assay	NULL
was	NULL
performed	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
either	NULL
edce2-expressing	NULL
or	NULL
edc2	NULL
nonexpressing	NULL
hematopoietic	NULL
cells	NULL
.	NULL

A	NULL
87-bp	NULL
BbilI-BamII	NULL
fragment	NULL
of	NULL
the	NULL
5'-regulatory	NULL
sequence	NULL
of	NULL
ecde2	NULL
gene	NULL
containing	NULL
a	NULL
putative	NULL
E2F	NULL
binding	NULL
site	NULL
and	NULL
two	NULL
RCEs	NULL
was	NULL
end-labeled	NULL
with	NULL
Escherichia	NULL
coli	NULL
DNA	NULL
polymerase	NULL
I	NULL
Klenow	NULL
fragment	NULL
,	NULL
purified	NULL
with	NULL
8	NULL
%	NULL
native	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
and	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
for	NULL
gel	NULL
retardation	NULL
assays	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
for	NULL
the	NULL
sequence	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
multiple	NULL
bands	NULL
with	NULL
retarded	NULL
mobilities	NULL
were	NULL
present	NULL
in	NULL
the	NULL
nuclear	NULL
extracts	NULL
from	NULL
HL-60	NULL
cell	NULL
line	NULL
and	NULL
from	NULL
both	NULL
resting	NULL
and	NULL
PHA-stimulated	NULL
T-lymphocytes	NULL
,	NULL
whereas	NULL
no	NULL
retarded	NULL
bands	NULL
were	NULL
observed	NULL
in	NULL
those	NULL
from	NULL
granulocytes	NULL
and	NULL
monocytes	NULL
before	NULL
and	NULL
after	NULL
the	NULL
culture	NULL
with	NULL
CSFs	NULL
.	NULL

The	NULL
patterns	NULL
of	NULL
the	NULL
appearance	NULL
of	NULL
these	NULL
bands	NULL
were	NULL
almost	NULL
identical	NULL
to	NULL
those	NULL
of	NULL
E2F	NULL
reported	NULL
by	NULL
others	NULL
(	NULL
49-52	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
these	NULL
complexes	NULL
represent	NULL
the	NULL
specific	NULL
E2F	NULL
binding	NULL
,	NULL
the	NULL
oligonucleotide	NULL
competition	NULL
assay	NULL
was	NULL
performed	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
all	NULL
bands	NULL
were	NULL
completely	NULL
eliminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
competitor	NULL
oligonucleotide	NULL
containing	NULL
E2F	NULL
binding	NULL
site	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
unlabeled	NULL
oligonucleotides	NULL
containing	NULL
either	NULL
AP-1	NULL
or	NULL
SP-1	NULL
binding	NULL
site	NULL
did	NULL
not	NULL
affect	NULL
these	NULL
complexes	NULL
.	NULL

Deoxycholate	NULL
treatment	NULL
and	NULL
antibody	NULL
perturbation	NULL
experiments	NULL
revealed	NULL
that	NULL
the	NULL
slowest	NULL
migrating	NULL
band	NULL
in	NULL
PHA-stimulated	NULL
T-lymphocytes	NULL
and	NULL
HL-60	NULL
cells	NULL
contained	NULL
cyclin	NULL
A	NULL
and	NULL
that	NULL
the	NULL
fastest	NULL
migrating	NULL
band	NULL
,	NULL
which	NULL
occasionally	NULL
appeared	NULL
as	NULL
a	NULL
doublet	NULL
representing	NULL
so-called	NULL
free	NULL
E2F	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Simi-larly	NULL
,	NULL
the	NULL
band	NULL
with	NULL
intermediate	NULL
mobility	NULL
was	NULL
shown	NULL
to	NULL
con	NULL
ede2	NULL
Expression	NULL
in	NULL
Hematopoietic	NULL
Cells	NULL
(	NULL
A	NULL
)	NULL
HL-60	NULL
cells	NULL
c	NULL
d	NULL
c	NULL
2	NULL
9.4	NULL
6.6	NULL
4.4	NULL
0	NULL
0.4	NULL
0.8	NULL
1.0	NULL
1.2	NULL
1.4	NULL
DNase	NULL
(	NULL
ug/ml	NULL
)	NULL
(	NULL
B	NULL
)	NULL
T-lymphocytes	NULL
1.0	NULL
o	NULL
04	NULL
0.8	NULL
mP	NULL
O	NULL
0	NULL
0.2	NULL
0.4	NULL
0.6	NULL
0.8	NULL
DNase	NULL
(	NULL
ug/ml	NULL
)	NULL
m	NULL
Â«	NULL
0	NULL
0.4	NULL
0.8	NULL
1.0	NULL
DNase	NULL
(	NULL
ug/ml	NULL
!	NULL
)	NULL

Fic	NULL
.	NULL

3	NULL
.	NULL

DNase	NULL
I	NULL
hypersensitivity	NULL
assay	NULL
of	NULL
HL-60	NULL
cells	NULL
and	NULL
T-lymphocytes	NULL
.	NULL

A	NULL
,	NULL
isolated	NULL
nuclei	NULL
from	NULL
HL-60	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
DNase	NULL
I	NULL
(	NULL
0-1.4	NULL
ug/ml	NULL
)	NULL
.	NULL

DNA	NULL
was	NULL
isolated	NULL
,	NULL
electrophoresed	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
P-labeled	NULL
myeloperoxidase	NULL
probe	NULL
(	NULL
right	NULL
)	NULL
and	NULL
5'-cdc2	NULL
probe	NULL
(	NULL
left	NULL
)	NULL
.	NULL

Germline	NULL
band	NULL
(	NULL
G	NULL
)	NULL
is	NULL
indicated	NULL
by	NULL
long	NULL
arrows	NULL
,	NULL
and	NULL
subbands	NULL
by	NULL
short	NULL
arrows	NULL
.	NULL

HS	NULL
means	NULL
DNaseI	NULL
hypersensitivity	NULL
site	NULL
.	NULL

HindIII-digested	NULL
A	NULL
DNA	NULL
was	NULL
used	NULL
as	NULL
a	NULL
molecular	NULL
size	NULL
marker	NULL
,	NULL
and	NULL
the	NULL
position	NULL
of	NULL
each	NULL
band	NULL
is	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
side	NULL
.	NULL

B	NULL
,	NULL
the	NULL
same	NULL
analysis	NULL
on	NULL
the	NULL
cdc2	NULL
gene	NULL
@	NULL
-	NULL
HS-1	NULL
--	NULL
G	NULL
(	NULL
18kb	NULL
)	NULL
26253	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
T-lymphocytes	NULL
before	NULL
and	NULL
after	NULL
48	NULL
h	NULL
of	NULL
the	NULL
culture	NULL
with	NULL
PHA-P.	NULL
-377	NULL
-	NULL
TIAGAAGTGA	NULL
AAGIAAIGGA_AICTCGATGT	NULL
AAACACAATA	NULL
TCACTTTTTT	NULL
GTtAGAGcTAT	NULL
s-1	NULL
~311	NULL
-306	NULL
-291	NULL
-287	NULL
-317	NULL
-	NULL
TTTGAGTATA	NULL
ATAAATTTGA	NULL
ACTGTGCCAA	NULL
TGCTGGGAGA	NULL
AAAAATTTAA	NULL
AaGgaaGaAAcG	NULL
TATA	NULL
CAAT	NULL
S	NULL
ania	NULL
dane	NULL
Par	NULL
spose	NULL
257	NULL
GaGCGaacaG	NULL
TAGCTTCCTC	NULL
GTCCectGac	NULL
tacaAaaAcact	NULL
agcaceacac	NULL
Tcrccceact	NULL
latory	NULL
region	NULL
of	NULL
the	NULL
ede2	NULL
gene	NULL
.	NULL

Nucle-	NULL
~	NULL
otides	NULL
are	NULL
numbered	NULL
from	NULL
the	NULL
major	NULL
tran-	NULL
Bbill	NULL
sÂ¥es	NULL
Â«	NULL
159	NULL
scription	NULL
initiation	NULL
site	NULL
(	NULL
-1	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
_	NULL
-197	NULL
ceaceacace	NULL
trecectcec	NULL
corecetTttt	NULL
crteraccccce	NULL
of	NULL
TATA-like	NULL
element	NULL
and	NULL
CAAT	NULL
motif	NULL
are	NULL
aAgs-s	NULL
IR	NULL
RCE	NULL
underlined	NULL
.	NULL

Two	NULL
RCEs	NULL
are	NULL
boxed	NULL
,	NULL
and	NULL
the	NULL
-124	NULL
-117	NULL
-198	NULL
-106	NULL
putative	NULL
E2F	NULL
binding	NULL
site	NULL
is	NULL
shown	NULL
by	NULL
a	NULL
-137	NULL
cottrecrer	NULL
ttorrreece	NULL
actecectac	NULL
cteceergtc	NULL
double	NULL
underline	NULL
.	NULL

Bbill	NULL
and	NULL
BamII	NULL
sites	NULL
29s	NULL
o	NULL
Â©	NULL
ers	NULL
gail	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
prim-	NULL
R	NULL
ugs	NULL
-	NULL
77	NULL
ATTGGCTGCT	NULL
TTGAAAGTCT	NULL
ceatTGetGAa	NULL
aTccessecc	NULL
ctrtacceccs	NULL
ers	NULL
used	NULL
for	NULL
PCR	NULL
are	NULL
indicated	NULL
by	NULL
dashed	NULL
cree	NULL
h	NULL
arrows	NULL
(	NULL
8-1	NULL
,	NULL
S-2	NULL
,	NULL
AS-1	NULL
,	NULL
and	NULL
AS-2	NULL
)	NULL
.	NULL

a	NULL
mRNA	NULL
-	NULL
17	NULL
-	NULL
TGeactTtToaA	NULL
ACTGCTCltâECA	NULL
cTtTescTtTca	NULL
TTecamaatTts	NULL
Accoesacacc	NULL
AS-1	NULL
+	NULL
44	NULL
GacÃ©ceetTG	NULL
TTeTAGcTcÃ©	NULL
cTteceeccec	NULL
cececaataa	NULL
Primer	NULL
26254	NULL
(	NULL
A	NULL
)	NULL
;	NULL
-	NULL
--	NULL
_	NULL
E2F	NULL
cyclinA	NULL
dimes	NULL
--	NULL
_	NULL
E2F	NULL
Rb	NULL
~-	NULL
_	NULL
E2F	NULL
free	NULL
--	NULL
-	NULL
free	NULL
probe	NULL
0	NULL
48	NULL
0	NULL
24	NULL
0	NULL
48	NULL
I	NULL
mami	NULL
,	NULL
emel	NULL
Fermer	NULL
,	NULL
l	NULL
T-lymphocytes	NULL
Granulocytes	NULL
Monocytes	NULL
8	NULL
+	NULL
PHA	NULL
+	NULL
G-CSF	NULL
+	NULL
GM-CSF	NULL
(	NULL
B	NULL
)	NULL
(	NULL
C	NULL
)	NULL
wile	NULL
\	NULL
aotins	NULL
--	NULL
_	NULL
E2F	NULL
cyclinA	NULL
wikis	NULL
Ts	NULL
--	NULL
_	NULL
E2F	NULL
Rb	NULL
*	NULL
--	NULL
if	NULL
--	NULL
_	NULL
E2F	NULL
free	NULL
--	NULL
_	NULL
free	NULL
probe	NULL
sont	NULL
!	NULL

>	NULL
T	NULL
3110	NULL
1-49	NULL
os1t0	NULL
1Zq	NULL
ILL.	NULL
09	NULL
0	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

E2F	NULL
binding	NULL
activity	NULL
in	NULL
various	NULL
hematopoietic	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
T-lymphocytes	NULL
,	NULL
granulocytes	NULL
,	NULL
and	NULL
monocytes	NULL
before	NULL
and	NULL
after	NULL
the	NULL
culture	NULL
with	NULL
PHA	NULL
,	NULL
G-CSF	NULL
,	NULL
and	NULL
GM-CSF	NULL
,	NULL
respectively	NULL
.	NULL

Gel	NULL
retardation	NULL
assay	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
*P-labeled	NULL
Bbill-BamII	NULL
fragment	NULL
of	NULL
5'-regulatory	NULL
sequence	NULL
of	NULL
the	NULL
edc2	NULL
gene	NULL
.	NULL

HL-60	NULL
cell	NULL
line	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

E2Ffree	NULL
means	NULL
free	NULL
E2F	NULL
that	NULL
involves	NULL
the	NULL
interaction	NULL
of	NULL
a	NULL
single	NULL
E2F	NULL
molecule	NULL
with	NULL
the	NULL
probe	NULL
.	NULL

E2FcyclinA	NULL
and	NULL
E2FRb	NULL
indicate	NULL
E2F	NULL
present	NULL
in	NULL
a	NULL
complex	NULL
with	NULL
cyclinA	NULL
and	NULL
Rb	NULL
proteins	NULL
,	NULL
respectively	NULL
.	NULL

A	NULL
distinct	NULL
E2F	NULL
complex	NULL
with	NULL
an	NULL
unidentified	NULL
protein	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
asterisk	NULL
.	NULL

B	NULL
,	NULL
specificity	NULL
of	NULL
the	NULL
E2F	NULL
binding	NULL
was	NULL
confirmed	NULL
by	NULL
the	NULL
oligonucleotides	NULL
competition	NULL
assay	NULL
.	NULL

Gel	NULL
shift	NULL
assay	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
T-lymphocytes	NULL
cultured	NULL
with	NULL
PHA	NULL
for	NULL
48	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotides	NULL
containing	NULL
either	NULL
AP-1	NULL
,	NULL
SP-1	NULL
,	NULL
or	NULL
E2F	NULL
binding	NULL
site	NULL
.	NULL

C	NULL
,	NULL
E2F	NULL
activity	NULL
in	NULL
RB-deficient	NULL
cells	NULL
.	NULL

Nuclear	NULL
extract	NULL
was	NULL
isolated	NULL
from	NULL
a	NULL
RB-deficient	NULL
human	NULL
lung	NULL
cancer	NULL
cell	NULL
line	NULL
LUG65	NULL
,	NULL
and	NULL
gel-shift	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
above	NULL
.	NULL

T-lymphocytes	NULL
were	NULL
cultured	NULL
with	NULL
PHA	NULL
for	NULL
72	NULL
h	NULL
and	NULL
used	NULL
as	NULL
a	NULL
control	NULL
(	NULL
7-72	NULL
)	NULL
.	NULL

tain	NULL
Rb	NULL
.	NULL

These	NULL
bands	NULL
were	NULL
hereinafter	NULL
designated	NULL
as	NULL
E2FcyclinA	NULL
,	NULL
E2Ffree	NULL
,	NULL
and	NULL
E2FRb	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
mobility	NULL
of	NULL
the	NULL
most	NULL
prominent	NULL
band	NULL
in	NULL
resting	NULL
T-cells	NULL
(	NULL
asterisk	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
either	NULL
anti-Rb	NULL
,	NULL
anti-p107	NULL
,	NULL
or	NULL
anti-cyclin	NULL
A	NULL
.	NULL

However	NULL
,	NULL
this	NULL
band	NULL
was	NULL
also	NULL
eliminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
cold	NULL
E2F	NULL
oligonucleotides	NULL
,	NULL
suggesting	NULL
that	NULL
it	NULL
represents	NULL
a	NULL
distinct	NULL
E2F	NULL
complex	NULL
containing	NULL
cellular	NULL
proteins	NULL
other	NULL
than	NULL
Rb	NULL
,	NULL
p107	NULL
,	NULL
and	NULL
cyclin	NULL
A	NULL
.	NULL

These	NULL
results	NULL
confirmed	NULL
the	NULL
previous	NULL
findings	NULL
reported	NULL
by	NULL
Chittenden	NULL
et	NULL
al	NULL
.	NULL

(	NULL
52	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
or	NULL
not	NULL
these	NULL
bands	NULL
were	NULL
related	NULL
to	NULL
RCEs	NULL
,	NULL
the	NULL
same	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
nuclear	NULL
extract	NULL
from	NULL
RB-deficient	NULL
human	NULL
lung	NULL
cancer	NULL
cell	NULL
line	NULL
LUG65	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
E2FcyclinA	NULL
and	NULL
E2Ffree	NULL
were	NULL
present	NULL
in	NULL
a	NULL
lysate	NULL
from	NULL
LU65	NULL
cells	NULL
,	NULL
whereas	NULL
E2FRb	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
a	NULL
compatible	NULL
one	NULL
without	NULL
Rb	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

This	NULL
experiment	NULL
also	NULL
indicated	NULL
that	NULL
RCE-related	NULL
complex	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
this	NULL
condition	NULL
.	NULL

To	NULL
further	NULL
confirm	NULL
the	NULL
binding	NULL
specificity	NULL
,	NULL
in	NULL
vitro	NULL
DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
each	NULL
E2F	NULL
complex	NULL
ede2	NULL
Expression	NULL
in	NULL
Hematopoietic	NULL
Cells	NULL
(	NULL
A	NULL
)	NULL
_	NULL
209Â°	NULL
150000	NULL
S	NULL
;	NULL
100000	NULL
-	NULL
50000	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
(	NULL
B	NULL
)	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Promoter	NULL
activity	NULL
of	NULL
5'-regulatory	NULL
sequence	NULL
of	NULL
the	NULL
edc2	NULL
gene	NULL
.	NULL

Promoter	NULL
activity	NULL
of	NULL
5'-flanking	NULL
sequence	NULL
of	NULL
the	NULL
cdc2	NULL
gene	NULL
was	NULL
investigated	NULL
by	NULL
the	NULL
transient	NULL
transfection	NULL
assay	NULL
with	NULL
the	NULL
following	NULL
chloramphenicol	NULL
acetyltransferase	NULL
reporter	NULL
constructs	NULL
:	NULL
1	NULL
,	NULL
pCAT-basic	NULL
vector	NULL
;	NULL
2	NULL
,	NULL
pCAT-enhancer	NULL
vector	NULL
;	NULL
3	NULL
,	NULL
pCAT-control	NULL
vector	NULL
;	NULL
4	NULL
,	NULL
pCAT-basic	NULL
vector	NULL
containing	NULL
a	NULL
wild	NULL
type	NULL
5'-regulatory	NULL
sequence	NULL
of	NULL
ede2	NULL
(	NULL
-377	NULL
to	NULL
+90	NULL
)	NULL
;	NULL
5	NULL
,	NULL
pCAT-enhancer	NULL
vector	NULL
containing	NULL
a	NULL
wild	NULL
type	NULL
5-edc2	NULL
;	NULL
6	NULL
,	NULL
pCAT-basic	NULL
vector	NULL
containing	NULL
5'-regulatory	NULL
sequence	NULL
of	NULL
ede2	NULL
(	NULL
-377	NULL
to	NULL
+90	NULL
)	NULL
with	NULL
a	NULL
mutation	NULL
at	NULL
the	NULL
E2F	NULL
binding	NULL
site	NULL
;	NULL
7	NULL
,	NULL
pCAT-enhancer	NULL
vector	NULL
containing	NULL
a	NULL
mutant	NULL
5'-edc2	NULL
.	NULL

Chloramphenicol	NULL
acetyltransferase	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
duplicate	NULL
,	NULL
and	NULL
the	NULL
activities	NULL
were	NULL
measured	NULL
simultaneously	NULL
by	NULL
a	NULL
liquid	NULL
scintillation	NULL
counting	NULL
(	NULL
A	NULL
)	NULL
and	NULL
by	NULL
a	NULL
thin-layer	NULL
chromatography	NULL
(	NULL
B	NULL
)	NULL
according	NULL
to	NULL
the	NULL
standard	NULL
methods	NULL
.	NULL

B-galactosid-ase	NULL
activities	NULL
generally	NULL
varied	NULL
no	NULL
more	NULL
than	NULL
2-fold	NULL
between	NULL
different	NULL
extracts	NULL
,	NULL
indicating	NULL
that	NULL
transfection	NULL
efficiencies	NULL
between	NULL
plates	NULL
were	NULL
comparable	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

from	NULL
PHA-stimulated	NULL
T-lymphocytes	NULL
.	NULL

The	NULL
specific	NULL
binding	NULL
of	NULL
E2F	NULL
to	NULL
the	NULL
region	NULL
between	NULL
nucleotides	NULL
-124	NULL
to	NULL
-117	NULL
was	NULL
demonstrated	NULL
in	NULL
all	NULL
samples	NULL
including	NULL
E2FeyclinA	NULL
,	NULL
E2FRb	NULL
,	NULL
and	NULL
free	NULL
E2F	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
specific	NULL
E2F	NULL
binding	NULL
at	NULL
the	NULL
region	NULL
between	NULL
nucleotides	NULL
-124	NULL
to	NULL
-117	NULL
in	NULL
the	NULL
regulatory	NULL
sequence	NULL
of	NULL
the	NULL
cde2	NULL
gene	NULL
was	NULL
observed	NULL
in	NULL
concomitant	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
ede2	NULL
mRNA	NULL
transcripts	NULL
in	NULL
hematopoietic	NULL
cells	NULL
except	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
small	NULL
amount	NULL
of	NULL
distinct	NULL
E2F	NULL
complex	NULL
in	NULL
resting	NULL
T-lymphocytes	NULL
.	NULL

Although	NULL
the	NULL
role	NULL
of	NULL
two	NULL
RCEs	NULL
in	NULL
this	NULL
region	NULL
was	NULL
not	NULL
demonstrated	NULL
under	NULL
the	NULL
experimental	NULL
condition	NULL
in	NULL
this	NULL
study	NULL
,	NULL
the	NULL
involvement	NULL
of	NULL
other	NULL
protein	NULL
factors	NULL
including	NULL
RB	NULL
protein	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cde2	NULL
mRNA	NULL
expression	NULL
of	NULL
hematopoietic	NULL
cells	NULL
could	NULL
not	NULL
be	NULL
ruled	NULL
out	NULL
.	NULL

Further	NULL
investigation	NULL
should	NULL
be	NULL
required	NULL
to	NULL
clarify	NULL
this	NULL
point	NULL
.	NULL

Promoter	NULL
Activity	NULL
of	NULL
5'-Untranslated	NULL
Sequence	NULL
of	NULL
the	NULL
edc2	NULL
Gene-Promoter	NULL
activity	NULL
of	NULL
the	NULL
isolated	NULL
sequence	NULL
and	NULL
the	NULL
effect	NULL
of	NULL
E2F	NULL
binding	NULL
on	NULL
the	NULL
promoter	NULL
activity	NULL
were	NULL
investigated	NULL
by	NULL
a	NULL
transient	NULL
transfection	NULL
assay	NULL
of	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
reporter	NULL
constructs	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
a	NULL
467	NULL
fragment	NULL
encompassing	NULL
nucleotides	NULL
-377	NULL
to	NULL
+90	NULL
had	NULL
a	NULL
strong	NULL
promoter	NULL
activity	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
when	NULL
the	NULL
same	NULL
fragment	NULL
was	NULL
subcloned	NULL
into	NULL
a	NULL
pCAT-enhancer	NULL
vector	NULL
,	NULL
which	NULL
contains	NULL
ede2	NULL
Expression	NULL
in	NULL
Hematopoietic	NULL
Cells	NULL
T-cell	NULL
Granulocyte	NULL
0	NULL
48	NULL
O	NULL
24	NULL
PHA	NULL
_	NULL
GM-CSF	NULL
097H	NULL
I	NULL
26255	NULL
Monocyte	NULL
--	NULL
28s	NULL
rRNA	NULL
--	NULL
E2F	NULL
mRNA	NULL
(	NULL
3.1kb	NULL
)	NULL
o	NULL
24	NULL
48	NULL
72	NULL
GM-CSF	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

E2F-1/RBAP-1	NULL
mRNA	NULL
expression	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

The	NULL
membranes	NULL
used	NULL
in	NULL
the	NULL
experiments	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
were	NULL
rehybridized	NULL
with	NULL
P-labeled	NULL
cDNA	NULL
encoding	NULL
E2F-1/RBAP-1	NULL
.	NULL

SV40	NULL
enhancer	NULL
element	NULL
,	NULL
a	NULL
significant	NULL
reduction	NULL
of	NULL
the	NULL
promoter	NULL
activity	NULL
was	NULL
observed	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

This	NULL
result	NULL
suggests	NULL
the	NULL
presence	NULL
of	NULL
inhibitory	NULL
element	NULL
in	NULL
the	NULL
upstream	NULL
portion	NULL
of	NULL
this	NULL
segment	NULL
and	NULL
its	NULL
activation	NULL
by	NULL
the	NULL
SV40	NULL
enhancer	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
role	NULL
of	NULL
E2F	NULL
binding	NULL
on	NULL
the	NULL
promoter	NULL
activity	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
reporter	NULL
constructs	NULL
containing	NULL
a	NULL
mutant	NULL
E2F	NULL
binding	NULL
site	NULL
(	NULL
5'-TTTCGCGC-3	NULL
'	NULL
to	NULL
5'-TTTCGTAC-3	NULL
'	NULL
)	NULL
was	NULL
tested	NULL
in	NULL
the	NULL
same	NULL
manner	NULL
.	NULL

A	NULL
significant	NULL
reduction	NULL
of	NULL
the	NULL
promoter	NULL
activity	NULL
was	NULL
noted	NULL
both	NULL
in	NULL
pCAT-basic/5'-cdc2	NULL
and	NULL
in	NULL
pCAT-enhancer/5'-edc2	NULL
when	NULL
the	NULL
mutation	NULL
was	NULL
introduced	NULL
into	NULL
the	NULL
E2F	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
E2F	NULL
mRNA	NULL
in	NULL
Human	NULL
Primary	NULL
Hematopoietic	NULL
Cells-Recently	NULL
,	NULL
multiple	NULL
cDNAs	NULL
encoding	NULL
E2F-related	NULL
proteins	NULL
were	NULL
cloned	NULL
,	NULL
and	NULL
two	NULL
of	NULL
them	NULL
,	NULL
E2F-1/RBAP-1	NULL
(	NULL
33	NULL
)	NULL
and	NULL
DP-1	NULL
(	NULL
34	NULL
)	NULL
,	NULL
were	NULL
reported	NULL
to	NULL
encode	NULL
the	NULL
each	NULL
major	NULL
component	NULL
of	NULL
E2F	NULL
heterodimer	NULL
.	NULL

To	NULL
further	NULL
investigate	NULL
the	NULL
relationship	NULL
between	NULL
cdec2	NULL
mRNA	NULL
expression	NULL
and	NULL
E2F	NULL
in	NULL
hematopoietic	NULL
cells	NULL
,	NULL
the	NULL
membranes	NULL
used	NULL
in	NULL
the	NULL
experiments	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
were	NULL
rehybridized	NULL
with	NULL
P-labeled	NULL
E2F-1/RBAP-1	NULL
cDNA	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
an	NULL
authentic	NULL
3.1-kb	NULL
E2F-1	NULL
mRNA	NULL
transcript	NULL
was	NULL
readily	NULL
detected	NULL
in	NULL
ede2-expressors	NULL
(	NULL
PHA-stimulated	NULL
T-lymphocytes	NULL
,	NULL
HL-60	NULL
,	NULL
and	NULL
JOSK-I	NULL
cell	NULL
lines	NULL
)	NULL
.	NULL

No	NULL
E2F-1	NULL
mRNA	NULL
expression	NULL
was	NULL
observed	NULL
in	NULL
cde2	NULL
nonexpressors	NULL
(	NULL
resting	NULL
T-lymphocytes	NULL
,	NULL
granulocytes	NULL
,	NULL
and	NULL
monocytes	NULL
before	NULL
and	NULL
after	NULL
the	NULL
culture	NULL
)	NULL
.	NULL

This	NULL
is	NULL
fully	NULL
consistent	NULL
with	NULL
the	NULL
role	NULL
of	NULL
E2F	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cde2	NULL
mRNA	NULL
expression	NULL
as	NULL
described	NULL
above	NULL
.	NULL

A	NULL
more	NULL
detailed	NULL
time-course	NULL
experiment	NULL
was	NULL
performed	NULL
with	NULL
T-cell	NULL
culture	NULL
system	NULL
in	NULL
order	NULL
to	NULL
compare	NULL
the	NULL
induction	NULL
of	NULL
ede2	NULL
transcription	NULL
with	NULL
the	NULL
appearance	NULL
of	NULL
E2F	NULL
activity	NULL
.	NULL

As	NULL
reported	NULL
previously	NULL
(	NULL
18	NULL
,	NULL
25	NULL
,	NULL
53	NULL
,	NULL
54	NULL
)	NULL
,	NULL
almost	NULL
all	NULL
T-lymphocytes	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
were	NULL
in	NULL
G	NULL
,	NULL
-phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
before	NULL
the	NULL
stimulation	NULL
.	NULL

In	NULL
response	NULL
to	NULL
2	NULL
ug/ml	NULL
of	NULL
PHA-P	NULL
,	NULL
T-lymphocytes	NULL
were	NULL
synchronously	NULL
induced	NULL
to	NULL
undergo	NULL
blastogenesis	NULL
(	NULL
after	NULL
6-12	NULL
h	NULL
)	NULL
,	NULL
reach	NULL
G	NULL
,	NULL
/S	NULL
boundary	NULL
when	NULL
Rb	NULL
began	NULL
to	NULL
be	NULL
phosphorylated	NULL
(	NULL
after	NULL
24	NULL
h	NULL
)	NULL
,	NULL
begin	NULL
DNA	NULL
synthesis	NULL
(	NULL
after	NULL
36	NULL
h	NULL
)	NULL
,	NULL
and	NULL
initiate	NULL
mitosis	NULL
(	NULL
after	NULL
48	NULL
h	NULL
)	NULL
(	NULL
Figs	NULL
.	NULL

8	NULL
and	NULL
9	NULL
)	NULL
.	NULL

RNA	NULL
was	NULL
isolated	NULL
at	NULL
given	NULL
time	NULL
points	NULL
in	NULL
this	NULL
culture	NULL
system	NULL
and	NULL
subjected	NULL
to	NULL
Northern	NULL
blot	NULL
analysis	NULL
for	NULL
E2F-1	NULL
mRNA	NULL
expression	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
E2F-1	NULL
mRNA	NULL
was	NULL
induced	NULL
after	NULL
24	NULL
h	NULL
of	NULL
the	NULL
culture	NULL
with	NULL
PHA	NULL
when	NULL
T-lymphocytes	NULL
reached	NULL
G	NULL
,	NULL
/S	NULL
boundary	NULL
.	NULL

Expression	NULL
of	NULL
DP-1	NULL
mRNA	NULL
,	NULL
another	NULL
member	NULL
of	NULL
the	NULL
E2F	NULL
gene	NULL
family	NULL
,	NULL
was	NULL
examined	NULL
using	NULL
the	NULL
same	NULL
samples	NULL
.	NULL

DP-1	NULL
mRNA	NULL
expression	NULL
was	NULL
also	NULL
induced	NULL
after	NULL
24	NULL
h	NULL
of	NULL
the	NULL
culture	NULL
,	NULL
although	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
message	NULL
was	NULL
weaker	NULL
than	NULL
that	NULL
of	NULL
E2F-1	NULL
mRNA	NULL
in	NULL
T-lymphocytes	NULL
.	NULL

Expression	NULL
of	NULL
both	NULL
E2F-1	NULL
and	NULL
DP-1	NULL
mRNAs	NULL
apparently	NULL
preceded	NULL
the	NULL
induction	NULL
of	NULL
cde2	NULL
mRNA	NULL
,	NULL
which	NULL
was	NULL
observed	NULL
after	NULL
36	NULL
h	NULL
in	NULL
this	NULL
system	NULL
.	NULL

Time	NULL
Course	NULL
of	NULL
the	NULL
Induction	NULL
of	NULL
E2F	NULL
Activity	NULL
in	NULL
Tlym-phocytes-Induction	NULL
of	NULL
E2F	NULL
activity	NULL
was	NULL
analyzed	NULL
in	NULL
more	NULL
detail	NULL
by	NULL
gel	NULL
retardation	NULL
assays	NULL
using	NULL
the	NULL
same	NULL
system	NULL
in	NULL
order	NULL
to	NULL
confirm	NULL
the	NULL
role	NULL
of	NULL
E2F	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cde2	NULL
mRNA	NULL
expres-	NULL
T-lymphocytes	NULL
09~TH	NULL
edc2	NULL
mRNA	NULL
<	NULL
-	NULL
(	NULL
1.8kb	NULL
)	NULL
<	NULL
-	NULL
(	NULL
1.6kb	NULL
)	NULL
E2F-1	NULL
mRNA	NULL
<	NULL
-	NULL
(	NULL
3.1kb	NULL
)	NULL
DP-1	NULL
mRNA	NULL
â¬	NULL
&	NULL
n	NULL
<	NULL
-	NULL
(	NULL
2.8kb	NULL
)	NULL
(	NULL
oT	NULL
TI	NULL
Lsd	NULL
Lp	NULL
thad	NULL
Â£04	NULL
â	NULL
NW	NULL
â	NULL
MM	NULL
--	NULL
18	NULL
$	NULL
rRNA	NULL
0	NULL
6	NULL
12	NULL
24	NULL
36	NULL
48	NULL
72	NULL
(	NULL
h	NULL
)	NULL
=	NULL
=	NULL
ye	NULL
Â©	NULL
~	NULL
3	NULL
Â¥	NULL
Stimulation	NULL
Index	NULL
<	NULL
8	NULL
8	NULL
9	NULL
re	NULL
e	NULL
p	NULL
w	NULL
b	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
E2F	NULL
mRNA	NULL
in	NULL
T-lymphocytes	NULL
.	NULL

T-lymphocytes	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
2	NULL
ug/ml	NULL
of	NULL
PHA-P	NULL
up	NULL
to	NULL
72	NULL
h.	NULL
DNA	NULL
synthesis	NULL
was	NULL
monitored	NULL
by	NULL
[	NULL
Â°HJthymidine	NULL
uptake	NULL
,	NULL
and	NULL
stimulation	NULL
index	NULL
was	NULL
calculated	NULL
by	NULL
the	NULL
following	NULL
equation	NULL
;	NULL
(	NULL
cpm	NULL
at	NULL
the	NULL
given	NULL
time	NULL
point	NULL
)	NULL
/	NULL
(	NULL
cpm	NULL
at	NULL
0	NULL
h	NULL
)	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
the	NULL
induction	NULL
of	NULL
E2F-1	NULL
,	NULL
DP-1	NULL
,	NULL
and	NULL
ede2	NULL
mRNA	NULL
was	NULL
determined	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

HL-60	NULL
cell	NULL
line	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

Ethidium	NULL
bromide	NULL
staining	NULL
of	NULL
the	NULL
gel	NULL
is	NULL
shown	NULL
to	NULL
indicate	NULL
the	NULL
amounts	NULL
of	NULL
RNA	NULL
loaded	NULL
.	NULL

sion	NULL
.	NULL

Cell	NULL
cycle	NULL
profile	NULL
was	NULL
investigated	NULL
simultaneously	NULL
by	NULL
Rb	NULL
immunoblotting	NULL
and	NULL
*H-thymidine	NULL
uptake	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

9B	NULL
,	NULL
Rb	NULL
phosphorylation	NULL
occurred	NULL
after	NULL
24	NULL
h	NULL
of	NULL
the	NULL
culture	NULL
with	NULL
2	NULL
ug/ml	NULL
of	NULL
PHA-P	NULL
,	NULL
and	NULL
Â°H-thymidine	NULL
incorporation	NULL
started	NULL
after	NULL
36	NULL
h	NULL
,	NULL
indicating	NULL
that	NULL
T-lymphocytes	NULL
reached	NULL
G	NULL
,	NULL
/S	NULL
boundary	NULL
at	NULL
24	NULL
h	NULL
and	NULL
entered	NULL
S-phase	NULL
after	NULL
36	NULL
h.	NULL
E2F	NULL
activity	NULL
became	NULL
evident	NULL
after	NULL
24	NULL
h	NULL
as	NULL
expected	NULL
from	NULL
the	NULL
results	NULL
of	NULL
mRNA	NULL
ex	NULL
26256	NULL
hâ	NULL
probe	NULL
only	NULL
(	NULL
A	NULL
)	NULL
--	NULL
E2F	NULL
cyclinA	NULL
--	NULL
E2F	NULL
Rb	NULL
--	NULL
-	NULL
E2F	NULL
free	NULL
--	NULL
free	NULL
probe	NULL
(	NULL
B	NULL
)	NULL
ppl12-114	NULL
Rb	NULL
;	NULL
pl	NULL
10	NULL
Rb	NULL
0	NULL
6	NULL
12	NULL
-	NULL
24	NULL
36	NULL
48	NULL
72	NULL
(	NULL
h	NULL
)	NULL
5	NULL
E	NULL
g	NULL
g	NULL
E	NULL
g	NULL
g	NULL
Stimulation	NULL
Index	NULL
ta	NULL
in	NULL
t	NULL
Fic	NULL
.	NULL

9	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
the	NULL
induction	NULL
of	NULL
E2F	NULL
activity	NULL
in	NULL
T-lymphocytes	NULL
.	NULL

A	NULL
,	NULL
induction	NULL
of	NULL
E2F	NULL
activity	NULL
was	NULL
analyzed	NULL
in	NULL
more	NULL
detail	NULL
by	NULL
gel	NULL
retardation	NULL
assays	NULL
using	NULL
T-lymphocytes	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
four	NULL
distinct	NULL
forms	NULL
of	NULL
E2F	NULL
present	NULL
in	NULL
T-lymphocytes	NULL
(	NULL
E2FcyclinA	NULL
,	NULL
E2FRb	NULL
,	NULL
E2Ffree	NULL
,	NULL
and	NULL
asterisk	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

B	NULL
,	NULL
cell	NULL
cycle	NULL
profile	NULL
was	NULL
examined	NULL
simultaneously	NULL
by	NULL
Rb	NULL
immunoblotting	NULL
and	NULL
[	NULL
Â°H	NULL
)	NULL
thymidine	NULL
uptake	NULL
,	NULL
which	NULL
is	NULL
shown	NULL
as	NULL
a	NULL
stimulation	NULL
index	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
underphosphorylated	NULL
Rb	NULL
(	NULL
p110Â®	NULL
``	NULL
)	NULL
and	NULL
phosphorylated	NULL
Rb	NULL
(	NULL
pp112-114	NULL
``	NULL
``	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

pression	NULL
.	NULL

All	NULL
three	NULL
forms	NULL
of	NULL
E2F	NULL
,	NULL
i.e	NULL
.	NULL

E2FcyclinA	NULL
,	NULL
E2FRb	NULL
,	NULL
and	NULL
E2Ffree	NULL
,	NULL
appeared	NULL
after	NULL
G	NULL
,	NULL
/S	NULL
transition	NULL
and	NULL
increased	NULL
during	NULL
S	NULL
and	NULL
G	NULL
,	NULL
/M	NULL
phases	NULL
(	NULL
Fig	NULL
.	NULL

9A	NULL
)	NULL
.	NULL

A	NULL
distinct	NULL
E2F	NULL
complex	NULL
was	NULL
present	NULL
within	NULL
12	NULL
h	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
in	NULL
G	NULL
,	NULL
and	NULL
G	NULL
,	NULL
phases	NULL
(	NULL
indicated	NULL
by	NULL
asterisk	NULL
)	NULL
,	NULL
confirming	NULL
the	NULL
data	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

A	NULL
small	NULL
amounts	NULL
of	NULL
free	NULL
E2F	NULL
and	NULL
E2FRb	NULL
were	NULL
also	NULL
observed	NULL
during	NULL
this	NULL
period	NULL
.	NULL

DISCUSSION	NULL
Cell	NULL
cycle	NULL
regulation	NULL
is	NULL
known	NULL
to	NULL
be	NULL
very	NULL
important	NULL
for	NULL
the	NULL
control	NULL
of	NULL
hematopoietic	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
indicate	NULL
that	NULL
pluripotent	NULL
hematopoietic	NULL
stem	NULL
cells	NULL
are	NULL
in	NULL
G/G	NULL
,	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
and	NULL
,	NULL
after	NULL
triggered	NULL
into	NULL
cell	NULL
cycle	NULL
with	NULL
specific	NULL
hematopoietic	NULL
growth	NULL
factors	NULL
,	NULL
they	NULL
proliferate	NULL
at	NULL
relatively	NULL
constant	NULL
doubling	NULL
rates	NULL
during	NULL
the	NULL
early	NULL
stages	NULL
of	NULL
differentiation	NULL
(	NULL
55	NULL
)	NULL
.	NULL

As	NULL
a	NULL
result	NULL
,	NULL
a	NULL
significant	NULL
portion	NULL
(	NULL
20-40	NULL
%	NULL
)	NULL
of	NULL
the	NULL
committed	NULL
progenitors	NULL
such	NULL
as	NULL
granulocyte-macrophage	NULL
colony-forming	NULL
units	NULL
and	NULL
erythroid	NULL
burst-forming	NULL
units	NULL
and	NULL
the	NULL
morphologically	NULL
identifiable	NULL
precursors	NULL
such	NULL
as	NULL
myeloblasts	NULL
and	NULL
promyelocytes	NULL
is	NULL
in	NULL
a	NULL
cycling	NULL
state	NULL
(	NULL
56	NULL
)	NULL
.	NULL

These	NULL
cells	NULL
gradually	NULL
lose	NULL
the	NULL
cell-cycling	NULL
capacity	NULL
along	NULL
with	NULL
differentiation	NULL
and	NULL
spontaneously	NULL
arrest	NULL
the	NULL
cycling	NULL
in	NULL
G/G	NULL
,	NULL
phase	NULL
when	NULL
released	NULL
into	NULL
the	NULL
peripheral	NULL
blood	NULL
as	NULL
functional	NULL
mature	NULL
cells	NULL
.	NULL

Mature	NULL
lymphocytes	NULL
can	NULL
be	NULL
induced	NULL
to	NULL
reenter	NULL
S	NULL
phase	NULL
after	NULL
exposed	NULL
to	NULL
mitogens	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
although	NULL
mature	NULL
myeloid	NULL
cells	NULL
(	NULL
monocytes	NULL
and	NULL
granulocytes	NULL
)	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
appropriate	NULL
stimulants	NULL
,	NULL
they	NULL
can	NULL
not	NULL
be	NULL
induced	NULL
to	NULL
undergo	NULL
DNA	NULL
synthesis	NULL
or	NULL
mitosis	NULL
and	NULL
,	NULL
thus	NULL
,	NULL
are	NULL
considered	NULL
to	NULL
be	NULL
terminally	NULL
differentiated	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
hematopoietic	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
should	NULL
be	NULL
closely	NULL
related	NULL
to	NULL
the	NULL
function	NULL
of	NULL
cell	NULL
cycle	NULL
control	NULL
genes	NULL
such	NULL
edc2	NULL
Expression	NULL
in	NULL
Hematopoietic	NULL
Cells	NULL
as	NULL
edc2	NULL
or	NULL
RB	NULL
as	NULL
previously	NULL
reported	NULL
(	NULL
18	NULL
,	NULL
25	NULL
,	NULL
53	NULL
,	NULL
54	NULL
)	NULL
.	NULL

It	NULL
is	NULL
well	NULL
known	NULL
that	NULL
eukaryotic	NULL
cell	NULL
cycle	NULL
is	NULL
tightly	NULL
regulated	NULL
by	NULL
cyclin-dependent	NULL
kinases	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Among	NULL
them	NULL
,	NULL
cde2	NULL
gene	NULL
is	NULL
most	NULL
extensively	NULL
investigated	NULL
and	NULL
is	NULL
considered	NULL
to	NULL
be	NULL
one	NULL
of	NULL
the	NULL
most	NULL
important	NULL
genes	NULL
in	NULL
a	NULL
cdk	NULL
gene	NULL
family	NULL
(	NULL
3-7	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
expression	NULL
of	NULL
ede2	NULL
mRNA	NULL
and	NULL
studied	NULL
the	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
of	NULL
its	NULL
regulation	NULL
in	NULL
normal	NULL
human	NULL
hematopoietic	NULL
cells	NULL
in	NULL
order	NULL
to	NULL
investigate	NULL
the	NULL
role	NULL
of	NULL
cde2	NULL
gene	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
hematopoietic	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
.	NULL

ede2	NULL
mRNA	NULL
transcripts	NULL
were	NULL
readily	NULL
detected	NULL
in	NULL
immature	NULL
bone	NULL
marrow	NULL
cells	NULL
and	NULL
became	NULL
undetectable	NULL
accompanied	NULL
with	NULL
the	NULL
cell	NULL
cycle	NULL
arrest	NULL
during	NULL
differentiation	NULL
.	NULL

Peripheral	NULL
blood	NULL
resting	NULL
cells	NULL
including	NULL
granulocytes	NULL
,	NULL
monocytes	NULL
,	NULL
and	NULL
T-lymphocytes	NULL
did	NULL
not	NULL
express	NULL
ede2	NULL
mRNA	NULL
transcripts	NULL
.	NULL

ecde2	NULL
mRNA	NULL
could	NULL
be	NULL
induced	NULL
in	NULL
T-lymphocytes	NULL
when	NULL
the	NULL
cells	NULL
reentered	NULL
the	NULL
cell	NULL
cycle	NULL
in	NULL
response	NULL
to	NULL
PHA-P	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
cde2	NULL
mRNA	NULL
could	NULL
not	NULL
be	NULL
induced	NULL
in	NULL
granulocytes	NULL
and	NULL
monocytes	NULL
even	NULL
after	NULL
the	NULL
culture	NULL
with	NULL
appropriate	NULL
CSFs	NULL
.	NULL

ede2	NULL
mRNA	NULL
was	NULL
constitutively	NULL
expressed	NULL
in	NULL
leukemic	NULL
cells	NULL
.	NULL

Then	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
mechanisms	NULL
of	NULL
the	NULL
regulation	NULL
of	NULL
cde2	NULL
mRNA	NULL
expression	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

The	NULL
changes	NULL
in	NULL
the	NULL
chromatin	NULL
structure	NULL
such	NULL
as	NULL
the	NULL
appearance	NULL
of	NULL
DNase	NULL
I	NULL
hypersensitivity	NULL
sites	NULL
or	NULL
the	NULL
alteration	NULL
of	NULL
DNA	NULL
methylation	NULL
pattern	NULL
were	NULL
not	NULL
observed	NULL
in	NULL
T-lymphocytes	NULL
even	NULL
after	NULL
the	NULL
induction	NULL
of	NULL
ede2	NULL
mRNA	NULL
expression	NULL
by	NULL
mitogenic	NULL
stimuli	NULL
,	NULL
although	NULL
hypersensitivity	NULL
sites	NULL
were	NULL
found	NULL
in	NULL
the	NULL
cdc2	NULL
gene	NULL
in	NULL
leukemic	NULL
cells	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
isolated	NULL
the	NULL
5'-flanking	NULL
sequence	NULL
of	NULL
the	NULL
cdc2	NULL
gene	NULL
by	NULL
a	NULL
ligation-mediated	NULL
PCR	NULL
and	NULL
found	NULL
the	NULL
putative	NULL
E2F	NULL
binding	NULL
site	NULL
and	NULL
two	NULL
RCEs	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
E2F	NULL
at	NULL
the	NULL
region	NULL
between	NULL
nucleotides	NULL
-124	NULL
to	NULL
-117	NULL
was	NULL
detected	NULL
by	NULL
a	NULL
gel-shift	NULL
assay	NULL
and	NULL
DNase	NULL
I	NULL
footprinting	NULL
in	NULL
PHA-stimulated	NULL
T-lymphocytes	NULL
coincidentally	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
cde2	NULL
mRNA	NULL
.	NULL

E2F	NULL
binding	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
both	NULL
granulocytes	NULL
and	NULL
monocytes	NULL
before	NULL
and	NULL
after	NULL
the	NULL
stimulation	NULL
.	NULL

Transient	NULL
chloramphenicol	NULL
acetyltransferase	NULL
assay	NULL
revealed	NULL
that	NULL
the	NULL
region	NULL
between	NULL
-377	NULL
and	NULL
+90	NULL
had	NULL
a	NULL
strong	NULL
promoter	NULL
activity	NULL
,	NULL
and	NULL
introduction	NULL
of	NULL
the	NULL
mutation	NULL
at	NULL
the	NULL
E2F	NULL
binding	NULL
site	NULL
(	NULL
5'-TTTCGCGC-3	NULL
'	NULL
to	NULL
5'-TTTCGATC-3	NULL
'	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
loss	NULL
of	NULL
the	NULL
promoter	NULL
activity	NULL
.	NULL

The	NULL
role	NULL
of	NULL
RCEs	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
ede2	NULL
mRNA	NULL
expression	NULL
was	NULL
not	NULL
demonstrated	NULL
in	NULL
this	NULL
study	NULL
.	NULL

In	NULL
consistent	NULL
with	NULL
the	NULL
above	NULL
results	NULL
,	NULL
E2F-1/RBAP-1	NULL
mRNA	NULL
was	NULL
not	NULL
detectable	NULL
in	NULL
granulocytes	NULL
,	NULL
monocytes	NULL
,	NULL
and	NULL
resting	NULL
T-lymphocytes	NULL
but	NULL
induced	NULL
after	NULL
24	NULL
h	NULL
of	NULL
the	NULL
mitogenic	NULL
stimulation	NULL
of	NULL
T-lymphocytes	NULL
.	NULL

A	NULL
more	NULL
detailed	NULL
time-course	NULL
study	NULL
with	NULL
T-lymphocyte	NULL
culture	NULL
system	NULL
revealed	NULL
that	NULL
three	NULL
distinct	NULL
forms	NULL
of	NULL
E2F	NULL
(	NULL
E2Ffree	NULL
,	NULL
E2FRb	NULL
,	NULL
and	NULL
E2FcyclinA	NULL
)	NULL
were	NULL
induced	NULL
after	NULL
24	NULL
h	NULL
of	NULL
the	NULL
stimulation	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
at	NULL
(	NULL
G	NULL
,	NULL
/S	NULL
boundary	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
suggested	NULL
that	NULL
this	NULL
induction	NULL
of	NULL
E2F	NULL
activity	NULL
was	NULL
due	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
mRNAs	NULL
of	NULL
two	NULL
major	NULL
components	NULL
of	NULL
E2F	NULL
gene	NULL
family	NULL
,	NULL
E2F-1/RBAP-1	NULL
and	NULL
DP-1	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
E2F	NULL
activity	NULL
apparently	NULL
preceded	NULL
the	NULL
appearance	NULL
of	NULL
ede2	NULL
mRNA	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
role	NULL
of	NULL
E2F	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
edc2	NULL
mRNA	NULL
expression	NULL
.	NULL

E2F	NULL
is	NULL
a	NULL
mammalian	NULL
transcription	NULL
factor	NULL
that	NULL
was	NULL
originally	NULL
detected	NULL
as	NULL
a	NULL
cellular	NULL
protein	NULL
involved	NULL
in	NULL
activation	NULL
of	NULL
the	NULL
ad-enovirus	NULL
E2	NULL
promoter	NULL
(	NULL
57	NULL
)	NULL
.	NULL

Subsequent	NULL
studies	NULL
have	NULL
revealed	NULL
that	NULL
E2F	NULL
may	NULL
also	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
cell	NULL
cycle	NULL
control	NULL
of	NULL
many	NULL
types	NULL
of	NULL
mammalian	NULL
cells	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

58	NULL
)	NULL
.	NULL

The	NULL
promoter	NULL
region	NULL
of	NULL
several	NULL
important	NULL
genes	NULL
including	NULL
e-myc	NULL
,	NULL
N-mye	NULL
,	NULL
c-myb	NULL
,	NULL
epidermal	NULL
growth	NULL
factor	NULL
receptor	NULL
,	NULL
and	NULL
dihydrofolate	NULL
reductase	NULL
contains	NULL
sequences	NULL
similar	NULL
to	NULL
the	NULL
E2F	NULL
binding	NULL
site	NULL
(	NULL
consensus	NULL
sequence	NULL
,	NULL
TTTCGCGC	NULL
)	NULL
of	NULL
the	NULL
E2	NULL
promoter	NULL
.	NULL

For	NULL
c-mye	NULL
and	NULL
dihydrofolate	NULL
reductase	NULL
,	NULL
this	NULL
promoter	NULL
sequence	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
sufficient	NULL
to	NULL
activate	NULL
gene	NULL
transcription	NULL
(	NULL
59	NULL
)	NULL
.	NULL

E2F	NULL
activity	NULL
appears	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
formation	NULL
of	NULL
the	NULL
complex	NULL
with	NULL
other	NULL
cellular	NULL
proteins	NULL
.	NULL

E2F	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
Rb	NULL
,	NULL
the	NULL
Rb-related	NULL
protein	NULL
p107	NULL
,	NULL
cyclinA	NULL
,	NULL
and	NULL
additional	NULL
cde2	NULL
Expression	NULL
in	NULL
Hematopoietic	NULL
Cells	NULL
unidentified	NULL
proteins	NULL
(	NULL
49-52	NULL
)	NULL
.	NULL

The	NULL
formation	NULL
and	NULL
dissociation	NULL
of	NULL
these	NULL
complexes	NULL
correlates	NULL
with	NULL
progression	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
and	NULL
recent	NULL
evidence	NULL
suggests	NULL
that	NULL
the	NULL
complexed	NULL
E2F	NULL
,	NULL
especially	NULL
in	NULL
a	NULL
form	NULL
associated	NULL
with	NULL
Rb	NULL
,	NULL
is	NULL
functionally	NULL
inactive	NULL
,	NULL
while	NULL
free	NULL
E2F	NULL
is	NULL
the	NULL
transcriptionally	NULL
active	NULL
(	NULL
60	NULL
)	NULL
.	NULL

E2F	NULL
from	NULL
HeLa	NULL
cells	NULL
fractionates	NULL
into	NULL
at	NULL
least	NULL
five	NULL
components	NULL
that	NULL
can	NULL
be	NULL
separated	NULL
into	NULL
two	NULL
complementation	NULL
groups	NULL
.	NULL

Reconstitution	NULL
of	NULL
full	NULL
E2F	NULL
activity	NULL
,	NULL
including	NULL
optimal	NULL
DNA	NULL
and	NULL
Rb	NULL
binding	NULL
,	NULL
requires	NULL
dimerization	NULL
of	NULL
two	NULL
proteins	NULL
,	NULL
one	NULL
from	NULL
each	NULL
group	NULL
(	NULL
61-63	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
several	NULL
cDNAs	NULL
encoding	NULL
proteins	NULL
with	NULL
properties	NULL
similar	NULL
to	NULL
EZF	NULL
from	NULL
HeLa	NULL
cells	NULL
have	NULL
been	NULL
cloned	NULL
(	NULL
33	NULL
,	NULL
34	NULL
,	NULL
64	NULL
,	NULL
65	NULL
)	NULL
.	NULL

Among	NULL
them	NULL
,	NULL
E2F-1/RBAP-1	NULL
and	NULL
E2F-2	NULL
belong	NULL
to	NULL
the	NULL
same	NULL
complementation	NULL
group	NULL
,	NULL
while	NULL
DP-1	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
second	NULL
group	NULL
and	NULL
heterodimerizes	NULL
with	NULL
E2F-1	NULL
to	NULL
form	NULL
high	NULL
affinity	NULL
E2F	NULL
.	NULL

The	NULL
E2F-1/DP-1	NULL
heterodimer	NULL
can	NULL
reveal	NULL
full	NULL
transactivating	NULL
activity	NULL
,	NULL
which	NULL
is	NULL
repressed	NULL
by	NULL
Rb	NULL
coexpres-sion	NULL
as	NULL
is	NULL
the	NULL
case	NULL
for	NULL
native	NULL
E2F	NULL
(	NULL
61-63	NULL
)	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
,	NULL
we	NULL
reported	NULL
the	NULL
presence	NULL
of	NULL
E2F	NULL
binding	NULL
site	NULL
at	NULL
the	NULL
position	NULL
of	NULL
nucleotides	NULL
-124	NULL
to	NULL
-117	NULL
of	NULL
5	NULL
'	NULL
-flanking	NULL
region	NULL
of	NULL
the	NULL
ede2	NULL
gene	NULL
,	NULL
and	NULL
found	NULL
that	NULL
EZF	NULL
actually	NULL
bound	NULL
to	NULL
this	NULL
region	NULL
in	NULL
PHA-stimulated	NULL
T-lymphocytes	NULL
coincident	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
cde2	NULL
mRNA	NULL
.	NULL

A	NULL
strong	NULL
promoter	NULL
activity	NULL
was	NULL
demonstrated	NULL
in	NULL
this	NULL
region	NULL
by	NULL
a	NULL
chloramphenicol	NULL
acetyltransferase	NULL
assay	NULL
,	NULL
and	NULL
the	NULL
promoter	NULL
activity	NULL
was	NULL
significantly	NULL
diminished	NULL
by	NULL
mutation	NULL
at	NULL
the	NULL
E2F	NULL
binding	NULL
site	NULL
.	NULL

In	NULL
our	NULL
analysis	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
negative-regulatory	NULL
region	NULL
at	NULL
the	NULL
upstream	NULL
of	NULL
the	NULL
E2F	NULL
binding	NULL
site	NULL
was	NULL
also	NULL
suggested	NULL
.	NULL

This	NULL
negative	NULL
regulation	NULL
might	NULL
be	NULL
mediated	NULL
through	NULL
RCE	NULL
at	NULL
the	NULL
position	NULL
of	NULL
nucleotides	NULL
-165	NULL
to	NULL
-159	NULL
,	NULL
although	NULL
the	NULL
binding	NULL
of	NULL
any	NULL
factors	NULL
to	NULL
this	NULL
region	NULL
was	NULL
not	NULL
detected	NULL
by	NULL
our	NULL
analysis	NULL
.	NULL

Using	NULL
T-lymphocyte	NULL
culture	NULL
system	NULL
,	NULL
we	NULL
also	NULL
demonstrated	NULL
that	NULL
E2F	NULL
activity	NULL
was	NULL
induced	NULL
at	NULL
G	NULL
,	NULL
/S	NULL
boundary	NULL
and	NULL
apparently	NULL
preceded	NULL
the	NULL
induction	NULL
of	NULL
cde2	NULL
mRNA	NULL
in	NULL
early	NULL
S-phase	NULL
.	NULL

This	NULL
induction	NULL
of	NULL
E2F	NULL
activity	NULL
might	NULL
be	NULL
due	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
E2F-1/RBAP-1	NULL
and	NULL
DP-1	NULL
mRNAs	NULL
,	NULL
which	NULL
are	NULL
required	NULL
for	NULL
full	NULL
E2F	NULL
activity	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
it	NULL
is	NULL
reasonable	NULL
to	NULL
speculate	NULL
that	NULL
EZF	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
positive	NULL
regulation	NULL
of	NULL
cdec2	NULL
mRNA	NULL
expression	NULL
and	NULL
,	NULL
thus	NULL
,	NULL
in	NULL
the	NULL
cell	NULL
cycle	NULL
control	NULL
of	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Recently	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
EZF	NULL
binding	NULL
site	NULL
at	NULL
5'-flanking	NULL
sequence	NULL
of	NULL
the	NULL
edc2	NULL
gene	NULL
has	NULL
been	NULL
reported	NULL
by	NULL
three	NULL
other	NULL
groups	NULL
(	NULL
20-22	NULL
)	NULL
.	NULL

However	NULL
,	NULL
there	NULL
are	NULL
some	NULL
controversies	NULL
about	NULL
the	NULL
role	NULL
of	NULL
E2F	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cde2	NULL
mRNA	NULL
expression	NULL
.	NULL

Dalton	NULL
(	NULL
20	NULL
)	NULL
reported	NULL
that	NULL
the	NULL
cde2	NULL
promoter	NULL
has	NULL
a	NULL
E2F	NULL
binding	NULL
site	NULL
that	NULL
is	NULL
required	NULL
for	NULL
repression	NULL
of	NULL
transcription	NULL
of	NULL
a	NULL
cde2	NULL
promoter	NULL
by	NULL
cotransfection	NULL
of	NULL
RB	NULL
plasmid	NULL
but	NULL
that	NULL
is	NULL
not	NULL
very	NULL
important	NULL
for	NULL
normal	NULL
promoter	NULL
activity	NULL
in	NULL
human	NULL
fibroblasts	NULL
,	NULL
since	NULL
a	NULL
edc2	NULL
promoter	NULL
lacking	NULL
a	NULL
E2F	NULL
site	NULL
showed	NULL
only	NULL
a	NULL
30	NULL
%	NULL
decrease	NULL
in	NULL
transcriptional	NULL
activity	NULL
.	NULL

Yamamoto	NULL
et	NULL
al	NULL
.	NULL

(	NULL
22	NULL
)	NULL
also	NULL
reported	NULL
that	NULL
the	NULL
region	NULL
between	NULL
-129	NULL
and	NULL
-116	NULL
mediates	NULL
the	NULL
basal	NULL
promoter	NULL
activity	NULL
,	NULL
although	NULL
upstream	NULL
sequence	NULL
between	NULL
-310	NULL
and	NULL
-208	NULL
is	NULL
required	NULL
for	NULL
a	NULL
full	NULL
activity	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Ku	NULL
et	NULL
al	NULL
.	NULL

(	NULL
21	NULL
)	NULL
reported	NULL
that	NULL
critical	NULL
sequence	NULL
for	NULL
a	NULL
promoter	NULL
activity	NULL
is	NULL
located	NULL
between	NULL
-253	NULL
and	NULL
-245	NULL
,	NULL
and	NULL
that	NULL
e-my6	NULL
is	NULL
more	NULL
important	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
ecde2	NULL
mRNA	NULL
expression	NULL
.	NULL

Our	NULL
present	NULL
study	NULL
is	NULL
somewhat	NULL
conflicting	NULL
with	NULL
these	NULL
reports	NULL
.	NULL

These	NULL
discrepancies	NULL
could	NULL
be	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
explained	NULL
by	NULL
the	NULL
differences	NULL
in	NULL
the	NULL
experimental	NULL
conditions	NULL
.	NULL

For	NULL
example	NULL
,	NULL
we	NULL
did	NULL
not	NULL
perform	NULL
overexpression	NULL
of	NULL
Rb	NULL
by	NULL
co-transfection	NULL
,	NULL
so	NULL
we	NULL
could	NULL
not	NULL
fully	NULL
activate	NULL
the	NULL
negative-regulatory	NULL
region	NULL
,	NULL
nor	NULL
did	NULL
we	NULL
use	NULL
NIH	NULL
3T3	NULL
cells	NULL
that	NULL
contain	NULL
structurally	NULL
different	NULL
Rb	NULL
from	NULL
the	NULL
human	NULL
counterpart	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
we	NULL
underestimated	NULL
the	NULL
role	NULL
of	NULL
the	NULL
negative	NULL
regulatory	NULL
sequence	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
together	NULL
with	NULL
the	NULL
previous	NULL
findings	NULL
that	NULL
proliferation	NULL
of	NULL
immature	NULL
bone	NULL
marrow	NULL
cells	NULL
and	NULL
mitogen-stimulated	NULL
T-lymphocytes	NULL
was	NULL
inhibited	NULL
by	NULL
antisense	NULL
oligonucleotides	NULL
against	NULL
ede2	NULL
(	NULL
18	NULL
,	NULL
24	NULL
)	NULL
,	NULL
our	NULL
present	NULL
results	NULL
indicate	NULL
that	NULL
ede2	NULL
26257	NULL
mRNA	NULL
expression	NULL
is	NULL
important	NULL
for	NULL
the	NULL
proliferation	NULL
and	NULL
cell	NULL
cycling	NULL
of	NULL
normal	NULL
human	NULL
hematopoietic	NULL
cells	NULL
and	NULL
that	NULL
the	NULL
failure	NULL
to	NULL
induce	NULL
edc2	NULL
expression	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
terminal	NULL
differentiation	NULL
of	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Although	NULL
our	NULL
results	NULL
clearly	NULL
demonstrated	NULL
that	NULL
ede2	NULL
transcription	NULL
in	NULL
hematopoietic	NULL
cells	NULL
correlates	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
active	NULL
E2F	NULL
in	NULL
vitro	NULL
,	NULL
the	NULL
physiological	NULL
significance	NULL
of	NULL
the	NULL
E2F	NULL
binding	NULL
to	NULL
the	NULL
edc2	NULL
promoter	NULL
remains	NULL
to	NULL
be	NULL
clarified	NULL
.	NULL

REFERENCES	NULL
.	NULL

Forsburg	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
and	NULL
Nurse	NULL
,	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

7	NULL
,	NULL
227-256	NULL
.	NULL

Hunt	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Semin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

2	NULL
,	NULL
213-222	NULL
.	NULL

Nurse	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Bissett	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1981	NULL
)	NULL
Nature	NULL
292	NULL
,	NULL
558-560	NULL
.	NULL

Dunphy	NULL
,	NULL
W.	NULL
(	NULL
G.	NULL
,	NULL
Brizuela	NULL
,	NULL
L.	NULL
,	NULL
Beach	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Newport	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cell	NULL
54	NULL
,	NULL
423-431	NULL
.	NULL

Gautier	NULL
,	NULL
J.	NULL
,	NULL
Norbury	NULL
,	NULL
C.	NULL
,	NULL
Lohka	NULL
,	NULL
M.	NULL
,	NULL
Nurse	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Maller	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cell	NULL
54	NULL
,	NULL
433-439	NULL
.	NULL

Draetta	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Beach	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Celf	NULL
54	NULL
,	NULL
17-26	NULL
.	NULL

Riabowol	NULL
,	NULL
K.	NULL
,	NULL
Draetta	NULL
,	NULL
G.	NULL
,	NULL
Brizuela	NULL
,	NULL
L.	NULL
,	NULL
Vandre	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Beach	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
57	NULL
,	NULL
393-401	NULL
.	NULL

Fang	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Newport	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cell	NULL
66	NULL
,	NULL
781-742	NULL
.	NULL

Quelle	NULL
,	NULL
D.	NULL
,	NULL
Ashmun	NULL
,	NULL
R.	NULL
,	NULL
Shurtleff	NULL
,	NULL
S.	NULL
,	NULL
Kato	NULL
,	NULL
J.	NULL
Y.	NULL
,	NULL
Bar-Sagi	NULL
,	NULL
D.	NULL
,	NULL
Roussel	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Sherr	NULL
,	NULL
C.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
1559-1571	NULL
10	NULL
.	NULL

Ohtsubo	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Roberts	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
259	NULL
,	NULL
1908-1912	NULL
11	NULL
.	NULL

Draetta	NULL
,	NULL
G.	NULL
,	NULL
Luca	NULL
,	NULL
F.	NULL
,	NULL
Westendorf	NULL
,	NULL
J.	NULL
,	NULL
Brizuela	NULL
,	NULL
L.	NULL
,	NULL
Ruderman	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Beach	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
56	NULL
,	NULL
829-838	NULL
12	NULL
.	NULL

Gould	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
and	NULL
Nurse	NULL
,	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
342	NULL
,	NULL
39-45	NULL
13	NULL
.	NULL

Gould	NULL
,	NULL
K.	NULL
,	NULL
Moreno	NULL
,	NULL
S.	NULL
,	NULL
Owen	NULL
,	NULL
D.	NULL
,	NULL
Sazer	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Nurse	NULL
,	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
3297-3309	NULL
14	NULL
.	NULL

McGowan	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Russell	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Reed	NULL
,	NULL
S.	NULL
I	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Bio	NULL
!	NULL

10	NULL
,	NULL
3847-3851	NULL
15	NULL
.	NULL

Welch	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
Wang	NULL
,	NULL
J.	NULL
Y.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
3098-3097	NULL
16	NULL
.	NULL

Durkacz	NULL
,	NULL
B.	NULL
,	NULL
Carr	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Nurse	NULL
,	NULL
P.	NULL
(	NULL
1986	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

5	NULL
,	NULL
369-373	NULL
17	NULL
.	NULL

Lee	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Norbury	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Spurr	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
and	NULL
Nurse	NULL
,	NULL
P.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
333	NULL
,	NULL
676-679	NULL
18	NULL
.	NULL

Furukawa	NULL
,	NULL
Y.	NULL
,	NULL
Piwnica-Worms	NULL
,	NULL
H.	NULL
,	NULL
Ernst	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Kanakura	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Griffin	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
250	NULL
,	NULL
805-808	NULL
19	NULL
.	NULL

Keyomarsi	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Pardee	NULL
,	NULL
A	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
1112-1116	NULL
20	NULL
.	NULL

Dalton	NULL
,	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
1797-1804	NULL
21	NULL
.	NULL

Ku	NULL
,	NULL
D.-H.	NULL
,	NULL
Wen	NULL
,	NULL
S.-C.	NULL
,	NULL
Engelhard	NULL
,	NULL
A.	NULL
,	NULL
Nicolaides	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
Lipson	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
Marino	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
Calabretta	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
2255-2259	NULL
22	NULL
.	NULL

Yamamoto	NULL
,	NULL
M.	NULL
,	NULL
Yoshida	NULL
,	NULL
M.	NULL
,	NULL
Ono	NULL
,	NULL
K.	NULL
,	NULL
Fujita	NULL
,	NULL
T.	NULL
,	NULL
Ohtani-Fujita	NULL
,	NULL
N.	NULL
,	NULL
Sakai	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Nikaido	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Exp	NULL
.	NULL

Cell	NULL
Res	NULL
.	NULL

210	NULL
,	NULL
94-101	NULL
23	NULL
.	NULL

Ogawa	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Blood	NULL
81	NULL
,	NULL
2844-2853	NULL
24	NULL
.	NULL

Lapidot-Lifson	NULL
,	NULL
Y.	NULL
,	NULL
Patinkin	NULL
,	NULL
D.	NULL
,	NULL
Prody	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Ehrlich	NULL
,	NULL
G.	NULL
,	NULL
Seidman	NULL
,	NULL
S.	NULL
,	NULL
Ben-Aziz	NULL
,	NULL
R.	NULL
,	NULL
Benseler	NULL
,	NULL
F.	NULL
,	NULL
Eckstein	NULL
,	NULL
F.	NULL
,	NULL
Zakut	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Soreq	NULL
,	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
579-583	NULL
25	NULL
.	NULL

Furukawa	NULL
,	NULL
Y.	NULL
,	NULL
DeCaprio	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Freedman	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Kanakura	NULL
,	NULL
Y.	NULL
,	NULL
Nakamura	NULL
,	NULL
M.	NULL
,	NULL
Ernst	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Livingston	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
and	NULL
Griffin	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
2770-2774	NULL
26	NULL
.	NULL

Yuo	NULL
,	NULL
A.	NULL
,	NULL
Kitagawa	NULL
,	NULL
S.	NULL
,	NULL
Motoyoshi	NULL
,	NULL
K.	NULL
,	NULL
Azuma	NULL
,	NULL
E.	NULL
,	NULL
Saito	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Takaku	NULL
,	NULL
F.	NULL
(	NULL
1992	NULL
)	NULL
Blood	NULL
79	NULL
,	NULL
1553-1557	NULL
27	NULL
.	NULL

Kitagawa	NULL
,	NULL
S.	NULL
,	NULL
Ohta	NULL
,	NULL
M.	NULL
,	NULL
Nojiri	NULL
,	NULL
H.	NULL
,	NULL
Kakinuma	NULL
,	NULL
K.	NULL
,	NULL
Saito	NULL
,	NULL
M.	NULL
,	NULL
Takaku	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Miura	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

73	NULL
,	NULL
1062~1071	NULL
28	NULL
.	NULL

Furukawa	NULL
,	NULL
Y.	NULL
,	NULL
Ohta	NULL
,	NULL
M.	NULL
,	NULL
Kasahara	NULL
,	NULL
T.	NULL
,	NULL
Miura	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Saito	NULL
,	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

47	NULL
,	NULL
2589-2598	NULL
29	NULL
.	NULL

Suzuki	NULL
,	NULL
K.	NULL
,	NULL
Miyasaka	NULL
,	NULL
H.	NULL
,	NULL
Ota	NULL
,	NULL
H.	NULL
,	NULL
Yamakawa	NULL
,	NULL
Y.	NULL
,	NULL
Tagawa	NULL
,	NULL
M.	NULL
,	NULL
Kuramoto	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Mizuno	NULL
,	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

169	NULL
,	NULL
1895-1901	NULL
30	NULL
.	NULL

Furukawa	NULL
,	NULL
Y.	NULL
,	NULL
Uenoyama	NULL
,	NULL
S.	NULL
,	NULL
Ohta	NULL
,	NULL
M.	NULL
,	NULL
Tsunoda	NULL
,	NULL
A.	NULL
,	NULL
Griffin	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Saito	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
17121-17127	NULL
31	NULL
.	NULL

Lee	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
and	NULL
Nurse	NULL
,	NULL
P.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
827	NULL
,	NULL
31-35	NULL
32	NULL
.	NULL

Hashinaka	NULL
,	NULL
K.	NULL
,	NULL
Nishio	NULL
,	NULL
C.	NULL
,	NULL
Hur	NULL
,	NULL
S.-J	NULL
.	NULL

,	NULL
Sakiyama	NULL
,	NULL
F.	NULL
,	NULL
Tsunasawa	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Yamada	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Biochemistry	NULL
27	NULL
,	NULL
5906-5914	NULL
33	NULL
.	NULL

Kaelin	NULL
,	NULL
W.	NULL
G.	NULL
,	NULL
Krek	NULL
,	NULL
W.	NULL
,	NULL
Sellers	NULL
,	NULL
W.	NULL
R.	NULL
,	NULL
DeCaprio	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Ajchenbaum	NULL
,	NULL
F.	NULL
,	NULL
Fuchs	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
Chittenden	NULL
,	NULL
T.	NULL
,	NULL
Li	NULL
,	NULL
Y.	NULL
,	NULL
Farnham	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Blanar	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Livingston	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
and	NULL
Flemington	NULL
,	NULL
E.	NULL
K.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
70	NULL
,	NULL
351-364	NULL
34	NULL
.	NULL

Girling	NULL
,	NULL
R.	NULL
,	NULL
Partridge	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Bandara	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
Burden	NULL
,	NULL
N.	NULL
,	NULL
Totty	NULL
,	NULL
N.	NULL
F.	NULL
,	NULL
Hsuan	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
and	NULL
La	NULL
Thangue	NULL
,	NULL
N.	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Nature	NULL
862	NULL
,	NULL
83-87	NULL
35	NULL
.	NULL

Lubbert	NULL
,	NULL
M.	NULL
,	NULL
Miller	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
and	NULL
Koeffler	NULL
,	NULL
H.	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
Blood	NULL
78	NULL
,	NULL
345-356	NULL
36	NULL
.	NULL

Fors	NULL
,	NULL
L.	NULL
,	NULL
Saavedra	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Hood	NULL
,	NULL
L.	NULL
(	NULL
1990	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18	NULL
,	NULL
2798-2799	NULL
37	NULL
.	NULL

Mueller	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
and	NULL
Wold	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Science	NULL
246	NULL
,	NULL
780-786	NULL
38	NULL
.	NULL

Brumley	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
Smith	NULL
,	NULL
L.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19	NULL
,	NULL
4121-4126	NULL
39	NULL
.	NULL

Chodosh	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
in	NULL
Short	NULL
Protocols	NULL
in	NULL
Molecular	NULL
Biology	NULL
,	NULL
pp	NULL
.	NULL

12-15	NULL
,	NULL
John	NULL
Wiley	NULL
&	NULL
Sons	NULL
,	NULL
Inc.	NULL
,	NULL
New	NULL
York	NULL
40	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Muller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
6419	NULL
41	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
211-217	NULL
42	NULL
.	NULL

Carthew	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
Chodosh	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
and	NULL
Sharp	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Cell	NULL
498	NULL
,	NULL
439-448	NULL
43	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Moffat	NULL
,	NULL
L.	NULL
F.	NULL
,	NULL
and	NULL
Howard	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1982	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
2	NULL
,	NULL
1044-1051	NULL
44	NULL
.	NULL

Seed	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Sheen	NULL
,	NULL
J.-Y	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Gene	NULL
(	NULL
Amst	NULL
.	NULL
)	NULL

67	NULL
,	NULL
271-277	NULL
45	NULL
.	NULL

Elledge	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Richman	NULL
,	NULL
R.	NULL
,	NULL
Hall	NULL
,	NULL
F.	NULL
L.	NULL
,	NULL
Williams	NULL
,	NULL
R.	NULL
T.	NULL
,	NULL
Lodgson	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Harper	NULL
,	NULL
J.	NULL
W.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
2907-2911	NULL
46	NULL
.	NULL

Welch	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
Wang	NULL
,	NULL
J.	NULL
Y.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
3093-3097	NULL
47	NULL
.	NULL

Lowrey	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Bodine	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
and	NULL
Nienhuis	NULL
,	NULL
A.	NULL
W.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
1148-1147	NULL
~10	NULL
or	NULL
im	NULL
00	NULL
N	NULL
1	NULL
w	NULL
o	NULL
26258	NULL
48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

Antequera	NULL
,	NULL
F.	NULL
,	NULL
Boyes	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Bird	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
503-514	NULL
Shirodkar	NULL
,	NULL
S.	NULL
,	NULL
Ewen	NULL
,	NULL
M.	NULL
,	NULL
DeCaprio	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Morgan	NULL
,	NULL
J.	NULL
,	NULL
Livingston	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
and	NULL
Chittenden	NULL
,	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
68	NULL
,	NULL
157-166	NULL
Devoto	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
Mudryj	NULL
,	NULL
M.	NULL
,	NULL
Pines	NULL
,	NULL
J.	NULL
,	NULL
Hunter	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Nevins	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
68	NULL
,	NULL
167-176	NULL
Schwarz	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Devoto	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
Smith	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
Chellappan	NULL
,	NULL
P.	NULL
,	NULL
Jakoi	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Nevins	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1998	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
1013-1020	NULL
Chittenden	NULL
,	NULL
T.	NULL
,	NULL
Livingston	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
and	NULL
DeCaprio	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
18	NULL
,	NULL
3975-3983	NULL
DeCaprio	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Ludlow	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Lynch	NULL
,	NULL
D.	NULL
,	NULL
Furukawa	NULL
,	NULL
Y.	NULL
,	NULL
Griffin	NULL
,	NULL
J.	NULL
,	NULL
Piwnica-Worms	NULL
,	NULL
H.	NULL
,	NULL
Huang	NULL
,	NULL
C.-M.	NULL
,	NULL
and	NULL
Livingston	NULL
,	NULL
D.	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
1085-1095	NULL
DeCaprio	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Furukawa	NULL
,	NULL
Y.	NULL
,	NULL
Ajchenbaum	NULL
,	NULL
F.	NULL
,	NULL
Griffin	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Livingston	NULL
,	NULL
D.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
1795-1798	NULL
Suda	NULL
,	NULL
T.	NULL
,	NULL
Suda	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Ogawa	NULL
,	NULL
M.	NULL
(	NULL
1983	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

117	NULL
,	NULL
308-318	NULL
Aglietta	NULL
,	NULL
M.	NULL
,	NULL
Piacibello	NULL
,	NULL
W.	NULL
,	NULL
Sanavio	NULL
,	NULL
F.	NULL
,	NULL
Stacchini	NULL
,	NULL
A.	NULL
,	NULL
Apra	NULL
,	NULL
F.	NULL
,	NULL
Schena	NULL
,	NULL
M.	NULL
,	NULL
Mossetti	NULL
,	NULL
C.	NULL
,	NULL
Carnino	NULL
,	NULL
F.	NULL
,	NULL
Caligaris-Cappio	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Gavosto	NULL
,	NULL
F.	NULL
(	NULL
1989	NULL
)	NULL
J	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65.	NULL
cde2	NULL
Expression	NULL
in	NULL
Hematopoietic	NULL
Cells	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

838	NULL
,	NULL
551-557	NULL
Kovesdi	NULL
,	NULL
I.	NULL
,	NULL
Reichel	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Nevins	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
45	NULL
,	NULL
219-228	NULL
Nevins	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
258	NULL
,	NULL
424-429	NULL
Mudryj	NULL
,	NULL
M.	NULL
,	NULL
Hiebert	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
and	NULL
Nevins	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
2179-2184	NULL
Weintraub	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Prater	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
Dean	NULL
,	NULL
D.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
Nature	NULL
$	NULL
58	NULL
,	NULL
259-261	NULL
Huber	NULL
,	NULL
H.	NULL
E.	NULL
,	NULL
Edwards	NULL
,	NULL
G.	NULL
,	NULL
Goodhart	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Patrick	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Huang	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Ivey-Hoyle	NULL
,	NULL
M.	NULL
,	NULL
Barnett	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Oliff	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Heimbrook	NULL
,	NULL
D.	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
8525-3529	NULL
Krek	NULL
,	NULL
W.	NULL
,	NULL
Livingston	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
and	NULL
Shirodkar	NULL
,	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
1557-1560	NULL
Bandara	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
Buck	NULL
,	NULL
V.	NULL
M.	NULL
,	NULL
Zamanian	NULL
,	NULL
M.	NULL
,	NULL
Johnson	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
and	NULL
La	NULL
Thangue	NULL
,	NULL
N.	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
4317-4324	NULL
Ivey-Hoyle	NULL
,	NULL
M.	NULL
,	NULL
Conroy	NULL
,	NULL
R.	NULL
,	NULL
Huber	NULL
,	NULL
H.	NULL
E.	NULL
,	NULL
Goodhart	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Oliff	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Heimbrook	NULL
,	NULL
D.	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
,	NULL
7802-7812	NULL
Lees	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Saito	NULL
,	NULL
M.	NULL
,	NULL
Vidal	NULL
,	NULL
M.	NULL
,	NULL
Valentine	NULL
,	NULL
M.	NULL
,	NULL
Look	NULL
,	NULL
T.	NULL
,	NULL
Harlow	NULL
,	NULL
E.	NULL
,	NULL
Dyson	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Helin	NULL
,	NULL
K.	NULL
(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
,	NULL
7813-7825	NULL

